Materiały źródłowe

• #1 Mixed connective tissue disease – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mixed-connective-tissue-disease/diagnosis-treatment/drc-20375152

  There’s no cure for mixed connective tissue disease. Medication can help manage the signs and symptoms. […] The type of medication prescribed depends on the severity of your disease and your symptoms. Medications can include: […] Corticosteroids. Drugs, such as prednisone (Deltasone, Rayos), can help prevent your immune system from attacking healthy cells and suppress inflammation. Side effects of corticosteroids can include mood swings, weight gain, high blood sugar, increased blood pressure, weakened bones and cataracts. […] Antimalarial drugs. Hydroxychloroquine (Plaquenil) can treat mild mixed connective tissue disease and might prevent flare-ups. […] Calcium channel blockers. This category of medications, including nifedipine (Adalat CC, Procardia) and amlodipine (Norvasc), that help relax the muscles in the walls of your blood vessels might be used to treat Raynaud’s phenomenon.

• #2 Mixed Connective Tissue Disease (MCTD): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15039-mixed-connective-tissue-disease

  Treatment for MCTD depends on which organs are affected, your symptoms and how severe your condition is. Some people may need treatment only during flare-ups, while others may require constant care. Theres no cure for the disease, but medication can help you manage your symptoms. MCTD medications may include: […] Corticosteroids. For mild cases of MCTD, low-dose corticosteroids like prednisone can reduce inflammation and prevent your immune system from attacking healthy cells. Higher doses may be needed for moderate to severe MCTD. […] Antimalarial drugs. Antimalarial drugs like hydroxychloroquine may help prevent flare-ups and can treat mild mixed connective tissue disease. […] Calcium channel blockers. To treat Raynauds phenomenon, your provider may suggest a calcium channel blocker to help relax the muscles in the walls of your blood vessels.

• #3 Mixed Connective-Tissue Disease (MCTD) Treatment & Management: Approach Considerations, Consultations, Diet and Activity

  https://emedicine.medscape.com/article/335815-treatment

  The overall goals of therapy for mixed connective-tissue disease (MCTD) are to control symptoms, to maintain function, and to reduce the risk of future disease consequences. Medical therapy targets control of disease activity in general and management of specific organ involvement, while monitoring for and mitigating the risks of complications either of the condition itself or of its treatment. […] Whenever possible, a rheumatologist experienced in diagnosis and treatment of the disease should co-manage all patients with mixed connective-tissue disease (MCTD). Consultation with other specialists or subspecialists may be indicated for the evaluation and/or treatment of specific aspects of disease, such as pulmonary hypertension, interstitial lung disease, gastroesophageal reflux, or acute ischemia due to Raynaud phenomenon.

• #4 Treatment of mixed connective tissue disease – PubMed

  https://pubmed.ncbi.nlm.nih.gov/16084325/

  Mixed connective tissue disease (MCTD) is believed to be incurable and seems to have a variable prognosis. Some patients have a mild self-limited disease, whereas others develop major organ involvement that requires aggressive treatment. Because no controlled clinical trials have been performed to guide therapy in MCTD, treatment strategies must rely largely upon the conventional therapies that are used for similar problems in other rheumatic conditions (systemic lupus erythematosus, scleroderma, polymyositis). Given the heterogeneous clinical course of MCTD, therapy should be individualized to address the specific organ involved and the severity of underlying disease activity. Corticosteroids, antimalarials, methotrexate, cytotoxics (most often cyclophosphamide), and vasodilators have been used in the treatment of MCTD with varying degrees of success.

• #5 Mixed Connective-Tissue Disease (MCTD) Treatment & Management: Approach Considerations, Consultations, Diet and Activity

  https://emedicine.medscape.com/article/335815-treatment

  The overall goals of therapy for mixed connective-tissue disease (MCTD) are to control symptoms, to maintain function, and to reduce the risk of future disease consequences. Medical therapy targets control of disease activity in general and management of specific organ involvement, while monitoring for and mitigating the risks of complications either of the condition itself or of its treatment. […] Whenever possible, a rheumatologist experienced in diagnosis and treatment of the disease should co-manage all patients with mixed connective-tissue disease (MCTD). Consultation with other specialists or subspecialists may be indicated for the evaluation and/or treatment of specific aspects of disease, such as pulmonary hypertension, interstitial lung disease, gastroesophageal reflux, or acute ischemia due to Raynaud phenomenon.

• #6 Mixed Connective Tissue Disease (MCTD): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15039-mixed-connective-tissue-disease

  Treatment for MCTD depends on which organs are affected, your symptoms and how severe your condition is. Some people may need treatment only during flare-ups, while others may require constant care. Theres no cure for the disease, but medication can help you manage your symptoms. MCTD medications may include: […] Corticosteroids. For mild cases of MCTD, low-dose corticosteroids like prednisone can reduce inflammation and prevent your immune system from attacking healthy cells. Higher doses may be needed for moderate to severe MCTD. […] Antimalarial drugs. Antimalarial drugs like hydroxychloroquine may help prevent flare-ups and can treat mild mixed connective tissue disease. […] Calcium channel blockers. To treat Raynauds phenomenon, your provider may suggest a calcium channel blocker to help relax the muscles in the walls of your blood vessels.

• #7 Mixed Connective Tissue Disease: Symptoms, Causes, and Treatment

  https://www.healthline.com/health/mixed-connective-tissue-disease

  Theres no cure for MCTD, but it can usually be managed with medication and lifestyle changes. […] Since this disease can affect various organs such as skin, muscle, the digestive system and lungs, as well as your joints, treatment is targeted to manage the major areas of involvement. […] First-line agents such as nonsteroidal anti-inflammatory agents can be used initially, but some patients may require more advanced treatment with the antimalarial drug hydroxychloroquine (Plaquenil) or other disease-modifying agents and biologics. […] Medication can help manage the symptoms of MCTD. Some people only require treatment of their disease when it flares up, but others may need long-term treatment. […] Medications used to treat MCTD include: Nonsteroidal anti-inflammatory drugs (NSAIDs). Over-the-counter NSAIDs, such as ibuprofen (Advil, Motrin) and naproxen (Aleve), can treat joint pain and inflammation.

• #8 Mixed Connective-Tissue Disease (MCTD) Treatment & Management: Approach Considerations, Consultations, Diet and Activity

  https://emedicine.medscape.com/article/335815-treatment

  The overall goals of therapy for mixed connective-tissue disease (MCTD) are to control symptoms, to maintain function, and to reduce the risk of future disease consequences. Medical therapy targets control of disease activity in general and management of specific organ involvement, while monitoring for and mitigating the risks of complications either of the condition itself or of its treatment. […] Whenever possible, a rheumatologist experienced in diagnosis and treatment of the disease should co-manage all patients with mixed connective-tissue disease (MCTD). Consultation with other specialists or subspecialists may be indicated for the evaluation and/or treatment of specific aspects of disease, such as pulmonary hypertension, interstitial lung disease, gastroesophageal reflux, or acute ischemia due to Raynaud phenomenon.

• #9 Mixed Connective Tissue Disease (MCTD) – Bone, Joint, and Muscle Disorders – Merck Manual Consumer Version

  https://www.merckmanuals.com/home/bone-joint-and-muscle-disorders/systemic-rheumatic-diseases/mixed-connective-tissue-disease-mctd

  Treatment varies depending on the severity of symptoms and may include nonsteroidal anti-inflammatory drugs, hydroxychloroquine, corticosteroids and other immunosuppressants, or a combination. […] The treatment of mixed connective tissue disease is similar to that of lupus, systemic sclerosis, and idiopathic inflammatory myopathy. Corticosteroids (a type of immunosuppressant) are usually effective, especially when the disease is diagnosed early. […] People who have mild disease can be treated with nonsteroidal anti-inflammatory drugs (NSAIDs), antimalarials (such as hydroxychloroquine or chloroquine), or very low doses of corticosteroids. […] People who have moderate to severe disease are given corticosteroids and sometimes other immunosuppressants (such as azathioprine, methotrexate, or mycophenolate mofetil).

• #10 Mixed Connective Tissue Disease: Symptoms, Causes, and Treatment

  https://www.healthline.com/health/mixed-connective-tissue-disease

  Theres no cure for MCTD, but it can usually be managed with medication and lifestyle changes. […] Since this disease can affect various organs such as skin, muscle, the digestive system and lungs, as well as your joints, treatment is targeted to manage the major areas of involvement. […] First-line agents such as nonsteroidal anti-inflammatory agents can be used initially, but some patients may require more advanced treatment with the antimalarial drug hydroxychloroquine (Plaquenil) or other disease-modifying agents and biologics. […] Medication can help manage the symptoms of MCTD. Some people only require treatment of their disease when it flares up, but others may need long-term treatment. […] Medications used to treat MCTD include: Nonsteroidal anti-inflammatory drugs (NSAIDs). Over-the-counter NSAIDs, such as ibuprofen (Advil, Motrin) and naproxen (Aleve), can treat joint pain and inflammation.

• #11 Mixed Connective Tissue Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK542198/

  The management of Raynaud phenomenon includes symptomatic strategies such as avoiding caffeine, smoking, cold temperatures, and injury to the digits. […] Arthritis and arthralgia typically respond to nonsteroidal anti-inflammatory drugs and hydroxychloroquine. […] Pleuritis, pericarditis, myositis, and aseptic meningitis typically respond to steroids. […] Gastrointestinal reflux treatment involves proton pump inhibitors (PPI) or histamine blockers, lifestyle changes, and dietary modifications, such as elevating the head of the bed and avoiding dietary triggers. […] Patients with autoimmune hemolytic anemia and thrombocytopenia are initially treated with steroids.

• #12 Mixed Connective Tissue Disease | Symptoms, Diagnosis & Treatment

  https://www.cincinnatichildrens.org/health/m/mctd

  There is no known cure for pediatric MCTD. But, there is effective treatment which can reduce or stop symptoms. This allows children with MCTD to lead healthy, productive lives. […] There is no specific treatment for MCTD. Treatment will be tailored to a child’s pattern of symptoms. Over time, some patients develop mild arthritis and need only symptom relief. Patients who develop lung disease will need steroids and other immune-suppressing medicines. […] Raynaud’s phenomenon responds well to protection from the cold, such as wearing mittens. Some children with Raynaud’s may need drugs, like calcium channel blockers. […] Medications used to treat children with MCTD include: […] Drugs like ibuprofen, naproxen, meloxicam and nabumetone are used to control the mild arthritis often seen in MCTD. Up to one-third of children get adequate disease control with the use of NSAIDs alone. Children tolerate these drugs very well. They uncommonly cause side effects like upset stomach.

• #13 Mixed Connective Tissue Disease | Symptoms, Diagnosis & Treatment

  https://www.cincinnatichildrens.org/health/m/mctd

  There is no known cure for pediatric MCTD. But, there is effective treatment which can reduce or stop symptoms. This allows children with MCTD to lead healthy, productive lives. […] There is no specific treatment for MCTD. Treatment will be tailored to a child’s pattern of symptoms. Over time, some patients develop mild arthritis and need only symptom relief. Patients who develop lung disease will need steroids and other immune-suppressing medicines. […] Raynaud’s phenomenon responds well to protection from the cold, such as wearing mittens. Some children with Raynaud’s may need drugs, like calcium channel blockers. […] Medications used to treat children with MCTD include: […] Drugs like ibuprofen, naproxen, meloxicam and nabumetone are used to control the mild arthritis often seen in MCTD. Up to one-third of children get adequate disease control with the use of NSAIDs alone. Children tolerate these drugs very well. They uncommonly cause side effects like upset stomach.

• #14 Mixed connective tissue disease – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mixed-connective-tissue-disease/diagnosis-treatment/drc-20375152

  There’s no cure for mixed connective tissue disease. Medication can help manage the signs and symptoms. […] The type of medication prescribed depends on the severity of your disease and your symptoms. Medications can include: […] Corticosteroids. Drugs, such as prednisone (Deltasone, Rayos), can help prevent your immune system from attacking healthy cells and suppress inflammation. Side effects of corticosteroids can include mood swings, weight gain, high blood sugar, increased blood pressure, weakened bones and cataracts. […] Antimalarial drugs. Hydroxychloroquine (Plaquenil) can treat mild mixed connective tissue disease and might prevent flare-ups. […] Calcium channel blockers. This category of medications, including nifedipine (Adalat CC, Procardia) and amlodipine (Norvasc), that help relax the muscles in the walls of your blood vessels might be used to treat Raynaud’s phenomenon.

• #15 Mixed Connective Tissue Disease (MCTD) – Bone, Joint, and Muscle Disorders – Merck Manual Consumer Version

  https://www.merckmanuals.com/home/bone-joint-and-muscle-disorders/systemic-rheumatic-diseases/mixed-connective-tissue-disease-mctd

  Treatment varies depending on the severity of symptoms and may include nonsteroidal anti-inflammatory drugs, hydroxychloroquine, corticosteroids and other immunosuppressants, or a combination. […] The treatment of mixed connective tissue disease is similar to that of lupus, systemic sclerosis, and idiopathic inflammatory myopathy. Corticosteroids (a type of immunosuppressant) are usually effective, especially when the disease is diagnosed early. […] People who have mild disease can be treated with nonsteroidal anti-inflammatory drugs (NSAIDs), antimalarials (such as hydroxychloroquine or chloroquine), or very low doses of corticosteroids. […] People who have moderate to severe disease are given corticosteroids and sometimes other immunosuppressants (such as azathioprine, methotrexate, or mycophenolate mofetil).

• #16 Mixed Connective Tissue Disease | Symptoms, Diagnosis & Treatment

  https://www.cincinnatichildrens.org/health/m/mctd

  Prednisone is the drug most often used in the group of medicines called steroids, corticosteroids or glucocorticoids. Other drugs in this group are methylprednisolone or prednisolone. Prednisone (or one of the other steroids) may be used to treat severe arthritis that does not respond to NSAIDs. It is also used to treat pulmonary hypertension. […] Prednisone works quickly to calm the immune system and control inflammation. This drug is like cortisone, a natural hormone made by our bodies. At first, high doses of this drug may be given to quickly reduce swelling in the joints, muscles, skin or lungs. As your child improves, the steroid dose will be reduced over time to prevent side effects that are common at higher doses. […] This antimalarial drug is used to treat MCTD and also lupus. It is a pill or pills taken one time a day. Though hydroxychloroquine is most often well-tolerated, some children may have stomach upset. […] For patients with more severe symptoms like lung, kidney or central nervous system disease, drugs called immunosuppressives may be used. These drugs calm the immune system by preventing new autoimmune cells from being formed.

• #17 Mixed Connective Tissue Disease (MCTD): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15039-mixed-connective-tissue-disease

  Treatment for MCTD depends on which organs are affected, your symptoms and how severe your condition is. Some people may need treatment only during flare-ups, while others may require constant care. Theres no cure for the disease, but medication can help you manage your symptoms. MCTD medications may include: […] Corticosteroids. For mild cases of MCTD, low-dose corticosteroids like prednisone can reduce inflammation and prevent your immune system from attacking healthy cells. Higher doses may be needed for moderate to severe MCTD. […] Antimalarial drugs. Antimalarial drugs like hydroxychloroquine may help prevent flare-ups and can treat mild mixed connective tissue disease. […] Calcium channel blockers. To treat Raynauds phenomenon, your provider may suggest a calcium channel blocker to help relax the muscles in the walls of your blood vessels.

• #18 Mixed Connective Tissue Disease (MCTD) – Musculoskeletal and Connective Tissue Disorders – MSD Manual Professional Edition

  https://www.msdmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/systemic-rheumatic-diseases/mixed-connective-tissue-disease-mctd

  Treatment varies with disease severity and organ involvement but usually includes corticosteroids and additional immunosuppressants. […] Nonsteroidal anti-inflammatory drugs (NSAIDs) or antimalarials (eg, hydroxychloroquine, chloroquine) for mild disease. […] Corticosteroids and other immunosuppressants (eg, methotrexate, azathioprine, mycophenolate mofetil) for moderate to severe disease. […] Calcium channel blockers (eg, nifedipine) and sometimes phosphodiesterase inhibitors (eg, tadalafil) for Raynaud syndrome. […] General management and initial pharmacologic therapy are extrapolated from approaches used for other systemic rheumatic diseases and are guided by the dominant clinical phenotype. […] Symptoms in patients with mild disease are often controlled by NSAIDs, antimalarials (eg, hydroxychloroquine, chloroquine), or sometimes low-dose corticosteroids.

• #19 Mixed Connective Tissue Disease | Symptoms, Diagnosis & Treatment

  https://www.cincinnatichildrens.org/health/m/mctd

  Prednisone is the drug most often used in the group of medicines called steroids, corticosteroids or glucocorticoids. Other drugs in this group are methylprednisolone or prednisolone. Prednisone (or one of the other steroids) may be used to treat severe arthritis that does not respond to NSAIDs. It is also used to treat pulmonary hypertension. […] Prednisone works quickly to calm the immune system and control inflammation. This drug is like cortisone, a natural hormone made by our bodies. At first, high doses of this drug may be given to quickly reduce swelling in the joints, muscles, skin or lungs. As your child improves, the steroid dose will be reduced over time to prevent side effects that are common at higher doses. […] This antimalarial drug is used to treat MCTD and also lupus. It is a pill or pills taken one time a day. Though hydroxychloroquine is most often well-tolerated, some children may have stomach upset. […] For patients with more severe symptoms like lung, kidney or central nervous system disease, drugs called immunosuppressives may be used. These drugs calm the immune system by preventing new autoimmune cells from being formed.

• #20 Mixed connective tissue disease – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mixed-connective-tissue-disease/diagnosis-treatment/drc-20375152

  There’s no cure for mixed connective tissue disease. Medication can help manage the signs and symptoms. […] The type of medication prescribed depends on the severity of your disease and your symptoms. Medications can include: […] Corticosteroids. Drugs, such as prednisone (Deltasone, Rayos), can help prevent your immune system from attacking healthy cells and suppress inflammation. Side effects of corticosteroids can include mood swings, weight gain, high blood sugar, increased blood pressure, weakened bones and cataracts. […] Antimalarial drugs. Hydroxychloroquine (Plaquenil) can treat mild mixed connective tissue disease and might prevent flare-ups. […] Calcium channel blockers. This category of medications, including nifedipine (Adalat CC, Procardia) and amlodipine (Norvasc), that help relax the muscles in the walls of your blood vessels might be used to treat Raynaud’s phenomenon.

• #21 Mixed Connective Tissue Disease (MCTD): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15039-mixed-connective-tissue-disease

  Quitting smoking. Smoking narrows your blood vessels, which makes the effects of Raynauds phenomenon worse. […] Reducing stress. Stress can trigger Raynauds phenomenon. Reduce your stress levels and practice relaxation techniques. Mental healthcare can also help you cope with stress. […] Long-term corticosteroid use can lead to side effects like: […] Bone loss due to osteoporosis […] Tissue death due to lack of blood flow (ischemia) […] Muscle weakness […] Infections […] Cushing syndrome. […] You must see your healthcare provider on a regular basis to monitor and control these possible effects. […] People who have a long-term, incurable condition like MCTD should develop ways of dealing with their disease. This includes: […] Seeking advice from your primary care provider.

• #22 Mixed Connective Tissue Disease (MCTD) – Bone, Joint, and Muscle Disorders – Merck Manual Consumer Version

  https://www.merckmanuals.com/home/bone-joint-and-muscle-disorders/systemic-rheumatic-diseases/mixed-connective-tissue-disease-mctd

  People who develop myositis or systemic sclerosis are treated for those diseases based on their symptoms. People who have Raynaud syndrome are treated based on their symptoms and may be given a calcium channel blocker (such as nifedipine) and medications that increase blood flow (such as sildenafil or tadalafil). […] People who take corticosteroids are at risk of fractures related to osteoporosis. To prevent osteoporosis, these people are given the medications used to treat osteoporosis, such as bisphosphonates and supplements of vitamin D and calcium. […] People who are receiving immunosuppressants are also given medications to prevent infections such as by the fungus Pneumocystis jirovecii and vaccines against common infections such as pneumonia, influenza, and COVID-19. […] Doctors monitor people with mixed connective tissue disease for pulmonary hypertension by doing pulmonary function testing, echocardiography, or both every 1 to 2 years, depending on symptoms.

• #23 Mixed connective tissue disease – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mixed-connective-tissue-disease/diagnosis-treatment/drc-20375152

  There’s no cure for mixed connective tissue disease. Medication can help manage the signs and symptoms. […] The type of medication prescribed depends on the severity of your disease and your symptoms. Medications can include: […] Corticosteroids. Drugs, such as prednisone (Deltasone, Rayos), can help prevent your immune system from attacking healthy cells and suppress inflammation. Side effects of corticosteroids can include mood swings, weight gain, high blood sugar, increased blood pressure, weakened bones and cataracts. […] Antimalarial drugs. Hydroxychloroquine (Plaquenil) can treat mild mixed connective tissue disease and might prevent flare-ups. […] Calcium channel blockers. This category of medications, including nifedipine (Adalat CC, Procardia) and amlodipine (Norvasc), that help relax the muscles in the walls of your blood vessels might be used to treat Raynaud’s phenomenon.

• #24 Mixed Connective Tissue Disease (MCTD): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15039-mixed-connective-tissue-disease

  Treatment for MCTD depends on which organs are affected, your symptoms and how severe your condition is. Some people may need treatment only during flare-ups, while others may require constant care. Theres no cure for the disease, but medication can help you manage your symptoms. MCTD medications may include: […] Corticosteroids. For mild cases of MCTD, low-dose corticosteroids like prednisone can reduce inflammation and prevent your immune system from attacking healthy cells. Higher doses may be needed for moderate to severe MCTD. […] Antimalarial drugs. Antimalarial drugs like hydroxychloroquine may help prevent flare-ups and can treat mild mixed connective tissue disease. […] Calcium channel blockers. To treat Raynauds phenomenon, your provider may suggest a calcium channel blocker to help relax the muscles in the walls of your blood vessels.

• #25 Mixed Connective Tissue Disease: Symptoms, Causes, and Treatment

  https://www.healthline.com/health/mixed-connective-tissue-disease

  Corticosteroids. Steroid medications, such as prednisone, can treat inflammation and help stop your immune system from attacking healthy tissues. […] Antimalarial drugs. Hydroxychloroquine (Plaquenil) can help with mild MCTD and probably help prevent flare-ups. […] Calcium channel blockers. Medications such as nifedipine (Procardia) and amlodipine (Norvasc) help manage Raynauds phenomenon. […] Immunosuppressants. Severe MCTD may require long-term treatment with immunosuppressants, which are drugs that suppress your immune system. […] Pulmonary hypertension drugs. Pulmonary hypertension is the leading cause of death among people with MCTD. […] In addition to medication, several lifestyle changes can also help: Get regular exercise as much as possible. […] If you smoke, try to quit.

• #26 Mixed Connective Tissue Disease | Symptoms, Diagnosis & Treatment

  https://www.cincinnatichildrens.org/health/m/mctd

  Prednisone is the drug most often used in the group of medicines called steroids, corticosteroids or glucocorticoids. Other drugs in this group are methylprednisolone or prednisolone. Prednisone (or one of the other steroids) may be used to treat severe arthritis that does not respond to NSAIDs. It is also used to treat pulmonary hypertension. […] Prednisone works quickly to calm the immune system and control inflammation. This drug is like cortisone, a natural hormone made by our bodies. At first, high doses of this drug may be given to quickly reduce swelling in the joints, muscles, skin or lungs. As your child improves, the steroid dose will be reduced over time to prevent side effects that are common at higher doses. […] This antimalarial drug is used to treat MCTD and also lupus. It is a pill or pills taken one time a day. Though hydroxychloroquine is most often well-tolerated, some children may have stomach upset. […] For patients with more severe symptoms like lung, kidney or central nervous system disease, drugs called immunosuppressives may be used. These drugs calm the immune system by preventing new autoimmune cells from being formed.

• #27 Undifferentiated Connective Tissue Disease – In-Depth | HSS

  https://www.hss.edu/conditions_undifferentiated-connective-tissue-disease-overview.asp

  It is unknown whether a particular therapy might decrease the risk of disease flare or of evolution to a defined connective tissue disease. Some data suggest that treatment with hydroxychloroquine may decrease the risk or delay possible progression of UCTD to lupus, but this has not yet been confirmed in randomized controlled trials. […] For other symptoms that are not addressed by these medications, doctors may prescribe oral corticosteroids such as prednisone or methylprednisolone (usually at low doses for short periods of time). In very rare cases, higher doses of corticosteroids or other immunosuppressive medications (such as methotrexate, azathioprine, mycophenolate, leflunomide, sulfasalazine, or others) may be used.

• #28 Mixed connective tissue disease – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mixed-connective-tissue-disease/diagnosis-treatment/drc-20375152

  There’s no cure for mixed connective tissue disease. Medication can help manage the signs and symptoms. […] The type of medication prescribed depends on the severity of your disease and your symptoms. Medications can include: […] Corticosteroids. Drugs, such as prednisone (Deltasone, Rayos), can help prevent your immune system from attacking healthy cells and suppress inflammation. Side effects of corticosteroids can include mood swings, weight gain, high blood sugar, increased blood pressure, weakened bones and cataracts. […] Antimalarial drugs. Hydroxychloroquine (Plaquenil) can treat mild mixed connective tissue disease and might prevent flare-ups. […] Calcium channel blockers. This category of medications, including nifedipine (Adalat CC, Procardia) and amlodipine (Norvasc), that help relax the muscles in the walls of your blood vessels might be used to treat Raynaud’s phenomenon.

• #29 Mixed Connective Tissue Disease (MCTD): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15039-mixed-connective-tissue-disease

  Treatment for MCTD depends on which organs are affected, your symptoms and how severe your condition is. Some people may need treatment only during flare-ups, while others may require constant care. Theres no cure for the disease, but medication can help you manage your symptoms. MCTD medications may include: […] Corticosteroids. For mild cases of MCTD, low-dose corticosteroids like prednisone can reduce inflammation and prevent your immune system from attacking healthy cells. Higher doses may be needed for moderate to severe MCTD. […] Antimalarial drugs. Antimalarial drugs like hydroxychloroquine may help prevent flare-ups and can treat mild mixed connective tissue disease. […] Calcium channel blockers. To treat Raynauds phenomenon, your provider may suggest a calcium channel blocker to help relax the muscles in the walls of your blood vessels.

• #30 Mixed connective tissue disease – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mixed-connective-tissue-disease/diagnosis-treatment/drc-20375152

  There’s no cure for mixed connective tissue disease. Medication can help manage the signs and symptoms. […] The type of medication prescribed depends on the severity of your disease and your symptoms. Medications can include: […] Corticosteroids. Drugs, such as prednisone (Deltasone, Rayos), can help prevent your immune system from attacking healthy cells and suppress inflammation. Side effects of corticosteroids can include mood swings, weight gain, high blood sugar, increased blood pressure, weakened bones and cataracts. […] Antimalarial drugs. Hydroxychloroquine (Plaquenil) can treat mild mixed connective tissue disease and might prevent flare-ups. […] Calcium channel blockers. This category of medications, including nifedipine (Adalat CC, Procardia) and amlodipine (Norvasc), that help relax the muscles in the walls of your blood vessels might be used to treat Raynaud’s phenomenon.

• #31 Mixed Connective Tissue Disease: Symptoms, Causes, and Treatment

  https://www.healthline.com/health/mixed-connective-tissue-disease

  Corticosteroids. Steroid medications, such as prednisone, can treat inflammation and help stop your immune system from attacking healthy tissues. […] Antimalarial drugs. Hydroxychloroquine (Plaquenil) can help with mild MCTD and probably help prevent flare-ups. […] Calcium channel blockers. Medications such as nifedipine (Procardia) and amlodipine (Norvasc) help manage Raynauds phenomenon. […] Immunosuppressants. Severe MCTD may require long-term treatment with immunosuppressants, which are drugs that suppress your immune system. […] Pulmonary hypertension drugs. Pulmonary hypertension is the leading cause of death among people with MCTD. […] In addition to medication, several lifestyle changes can also help: Get regular exercise as much as possible. […] If you smoke, try to quit.

• #32 Mixed Connective Tissue Disease | Treatment & Management | Point of Care

  https://www.statpearls.com/point-of-care/25207

  The management of Raynaud phenomenon includes symptomatic strategies such as avoiding caffeine, smoking, cold temperatures, and injury to the digits. Oral calcium channel blockers, such as nifedipine, which decreases peripheral resistance, are an option. […] Arthritis and arthralgia typically respond to nonsteroidal anti-inflammatory drugs and hydroxychloroquine. For refractory synovitis, corticosteroids, methotrexate, and other disease-modifying anti-rheumatic drugs can be used. […] Pleuritis, pericarditis, myositis, and aseptic meningitis typically respond to steroids. Steroid-sparing agents, such as methotrexate, cyclosporine, azathioprine, and mycophenolate mofetil, are commonly used as second-line agents. […] Patients with autoimmune hemolytic anemia and thrombocytopenia are initially treated with steroids. Clinicians can consider rituximab in resistant cases.

• #33 Mixed connective tissue disease – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mixed-connective-tissue-disease/diagnosis-treatment/drc-20375152

  Other immunosuppressants. Your doctor might prescribe other medications based on your signs and symptoms. For example, if they’re similar to those of lupus, your doctor might recommend medications typically prescribed for people with lupus. […] Pulmonary hypertension medications. Bosentan (Tracleer) or sildenafil (Revatio, Viagra) might be prescribed.

• #34 Mixed Connective Tissue Disease (MCTD): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15039-mixed-connective-tissue-disease

  Other immunosuppressants. If major organs are affected, you may need to take other immunosuppressants to suppress the actions of your immune system. […] Antihypertensive medications. Your provider may prescribe blood pressure medications to treat pulmonary hypertension. Pulmonary hypertension can lead to heart failure and many other serious complications. Its the most common cause of death in people with MCTD. […] If you have mixed connective tissue disease, youll likely need prescription medications to manage your symptoms. But you can also take steps to manage the disease on your own by: […] Taking nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs like ibuprofen (Advil or Motrin) and naproxen (Aleve), can help with mild pain and inflammation. […] Protecting your hands from the cold. Wear gloves in cold weather and do what you can to keep your hands warm to prevent Raynauds phenomenon.

• #35 Mixed Connective Tissue Disease (MCTD) – Bone, Joint, and Muscle Disorders – Merck Manual Consumer Version

  https://www.merckmanuals.com/home/bone-joint-and-muscle-disorders/systemic-rheumatic-diseases/mixed-connective-tissue-disease-mctd

  Treatment varies depending on the severity of symptoms and may include nonsteroidal anti-inflammatory drugs, hydroxychloroquine, corticosteroids and other immunosuppressants, or a combination. […] The treatment of mixed connective tissue disease is similar to that of lupus, systemic sclerosis, and idiopathic inflammatory myopathy. Corticosteroids (a type of immunosuppressant) are usually effective, especially when the disease is diagnosed early. […] People who have mild disease can be treated with nonsteroidal anti-inflammatory drugs (NSAIDs), antimalarials (such as hydroxychloroquine or chloroquine), or very low doses of corticosteroids. […] People who have moderate to severe disease are given corticosteroids and sometimes other immunosuppressants (such as azathioprine, methotrexate, or mycophenolate mofetil).

• #36 Mixed Connective-Tissue Disease (MCTD) Medication: Nonsteroidal anti-inflammatory drugs (NSAIDs), Proton pump inhibitors, Antimalarial agents, Corticosteroids, Phosphodiesterase (type 5) enzyme inhibitor, Endothelin receptor antagonists, Prostaglandins, I

  https://emedicine.medscape.com/article/335815-medication

  MCTD-related interstitial lung disease (ILD) is conventionally treated with corticosteroids in combination with steroid-sparing agents such as cyclophosphamide, azathioprine, or mycophenolate. […] The RECITAL trial, which included patients with MCTD, found that rituximab was noninferior to cyclophosphamide for treatment of ILD, and was associated with fewer adverse effects. […] The INBUILD trial, which included patients with MCTD, reported that treatment with the antifibrotic tyrosine kinase inhibitor nintedanib can significantly slow the annual rate of decline in forced vital capacity (FVC) in patients with progressive fibrosing ILDs. […] DMARDs used in the management of rheumatoid arthritis can be relevant in MCTD, in which a significant subset of patients have clinical manifestations that include those of chronic erosive polyarthritis, as is seen in rheumatoid arthritis. […] Increasingly, targeted therapies effective against other rheumatic diseases are emerging that may find a place in therapy for the overlapping rheumatic features in MCTD patients. A notable example is belimumab, a B-cell survival inhibitor that is approved for use in lupus.

• #37 Mixed Connective Tissue Disease (MCTD) | Doctor

  https://patient.info/doctor/mixed-connective-tissue-disease

  Adjuvant therapy with steroid-sparing agents such as cyclophosphamide and ciclosporin may be used when prolonged treatment with high-dose steroids is required. […] Calcium-channel blocking agents such as nifedipine may be used for the treatment of the Raynaud’s phenomenon. […] Oesophageal dysfunction may require treatment with proton pump inhibitors. […] Prostaglandins such as epoprostenol may be used to treat patients who have developed secondary pulmonary hypertension. […] Symptoms of pulmonary hypertension and Raynaud’s phenomenon can also be helped by phosphodiesterase inhibitors such as sildenafil. […] Endothelin receptor antagonists such as ambrisentan can help to reduce the symptoms of pulmonary hypertension and improve exercise tolerance.

• #38 Mixed Connective-Tissue Disease (MCTD) Medication: Nonsteroidal anti-inflammatory drugs (NSAIDs), Proton pump inhibitors, Antimalarial agents, Corticosteroids, Phosphodiesterase (type 5) enzyme inhibitor, Endothelin receptor antagonists, Prostaglandins, I

  https://emedicine.medscape.com/article/335815-medication

  MCTD-related interstitial lung disease (ILD) is conventionally treated with corticosteroids in combination with steroid-sparing agents such as cyclophosphamide, azathioprine, or mycophenolate. […] The RECITAL trial, which included patients with MCTD, found that rituximab was noninferior to cyclophosphamide for treatment of ILD, and was associated with fewer adverse effects. […] The INBUILD trial, which included patients with MCTD, reported that treatment with the antifibrotic tyrosine kinase inhibitor nintedanib can significantly slow the annual rate of decline in forced vital capacity (FVC) in patients with progressive fibrosing ILDs. […] DMARDs used in the management of rheumatoid arthritis can be relevant in MCTD, in which a significant subset of patients have clinical manifestations that include those of chronic erosive polyarthritis, as is seen in rheumatoid arthritis. […] Increasingly, targeted therapies effective against other rheumatic diseases are emerging that may find a place in therapy for the overlapping rheumatic features in MCTD patients. A notable example is belimumab, a B-cell survival inhibitor that is approved for use in lupus.

• #39 Mixed Connective Tissue Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK542198/

  Mixed connective tissue disease is a rare autoimmune disease characterized by the presence of the anti-U1-ribonucleoprotein, Raynaud phenomenon, and features of at least 2 connective tissue diseases, including systemic lupus erythematosus, systemic sclerosis, inflammatory myositis, and rheumatoid arthritis. […] Nonsteroidal anti-inflammatory drugs, steroids, and immunosuppressive agents are the mainstays of treatment. […] The main medications used to treat interstitial lung disease are mycophenolate mofetil, cyclophosphamide, and rituximab, with mycophenolate mofetil being the preferred initial therapy due to its comparable efficacy and fewer adverse effects compared to cyclophosphamide. […] Pulmonary hypertension is typically less responsive to steroids, and the guidance of an expert in pulmonary hypertension should direct advanced management.

• #40 Mixed Connective-Tissue Disease (MCTD) Medication: Nonsteroidal anti-inflammatory drugs (NSAIDs), Proton pump inhibitors, Antimalarial agents, Corticosteroids, Phosphodiesterase (type 5) enzyme inhibitor, Endothelin receptor antagonists, Prostaglandins, I

  https://emedicine.medscape.com/article/335815-medication

  MCTD-related interstitial lung disease (ILD) is conventionally treated with corticosteroids in combination with steroid-sparing agents such as cyclophosphamide, azathioprine, or mycophenolate. […] The RECITAL trial, which included patients with MCTD, found that rituximab was noninferior to cyclophosphamide for treatment of ILD, and was associated with fewer adverse effects. […] The INBUILD trial, which included patients with MCTD, reported that treatment with the antifibrotic tyrosine kinase inhibitor nintedanib can significantly slow the annual rate of decline in forced vital capacity (FVC) in patients with progressive fibrosing ILDs. […] DMARDs used in the management of rheumatoid arthritis can be relevant in MCTD, in which a significant subset of patients have clinical manifestations that include those of chronic erosive polyarthritis, as is seen in rheumatoid arthritis. […] Increasingly, targeted therapies effective against other rheumatic diseases are emerging that may find a place in therapy for the overlapping rheumatic features in MCTD patients. A notable example is belimumab, a B-cell survival inhibitor that is approved for use in lupus.

• #41 Mixed Connective Tissue Disease (MCTD) – Bone, Joint, and Muscle Disorders – Merck Manual Consumer Version

  https://www.merckmanuals.com/home/bone-joint-and-muscle-disorders/systemic-rheumatic-diseases/mixed-connective-tissue-disease-mctd

  People who develop myositis or systemic sclerosis are treated for those diseases based on their symptoms. People who have Raynaud syndrome are treated based on their symptoms and may be given a calcium channel blocker (such as nifedipine) and medications that increase blood flow (such as sildenafil or tadalafil). […] People who take corticosteroids are at risk of fractures related to osteoporosis. To prevent osteoporosis, these people are given the medications used to treat osteoporosis, such as bisphosphonates and supplements of vitamin D and calcium. […] People who are receiving immunosuppressants are also given medications to prevent infections such as by the fungus Pneumocystis jirovecii and vaccines against common infections such as pneumonia, influenza, and COVID-19. […] Doctors monitor people with mixed connective tissue disease for pulmonary hypertension by doing pulmonary function testing, echocardiography, or both every 1 to 2 years, depending on symptoms.

• #42 Mixed Connective Tissue Disease (MCTD) – Musculoskeletal and Connective Tissue Disorders – MSD Manual Professional Edition

  https://www.msdmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/systemic-rheumatic-diseases/mixed-connective-tissue-disease-mctd

  Most patients with moderate or severe disease respond to corticosteroids, particularly if treated early; however, corticosteroid use should be minimized when findings of systemic sclerosis are marked to avoid scleroderma renal crisis. […] Severe major organ involvement usually requires higher doses of corticosteroids (eg, oral prednisone 1 mg/kg once a day) and additional immunosuppressants. […] Patients with Raynaud syndrome should be treated based on their symptoms and as tolerated by their blood pressure with calcium channel blockers (eg, nifedipine) and phosphodiesterase inhibitors (eg, tadalafil). […] All patients should be closely monitored for atherosclerosis. Patients on long-term corticosteroid therapy should receive osteoporosis prophylaxis. […] If combination immunosuppressive therapy is used, patients should be given prophylaxis for opportunistic infections, such as Pneumocystis jirovecii, and vaccines against common infections (eg, streptococcal pneumonia, influenza, COVID-19). […] Some experts encourage screening for pulmonary hypertension on a periodic basis with pulmonary function testing and/or echocardiography every 1 to 2 years, depending on symptoms.

• #43 Mixed connective tissue disease – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mixed-connective-tissue-disease/diagnosis-treatment/drc-20375152

  Other immunosuppressants. Your doctor might prescribe other medications based on your signs and symptoms. For example, if they’re similar to those of lupus, your doctor might recommend medications typically prescribed for people with lupus. […] Pulmonary hypertension medications. Bosentan (Tracleer) or sildenafil (Revatio, Viagra) might be prescribed.

• #44 Mixed Connective Tissue Disease (MCTD): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15039-mixed-connective-tissue-disease

  Other immunosuppressants. If major organs are affected, you may need to take other immunosuppressants to suppress the actions of your immune system. […] Antihypertensive medications. Your provider may prescribe blood pressure medications to treat pulmonary hypertension. Pulmonary hypertension can lead to heart failure and many other serious complications. Its the most common cause of death in people with MCTD. […] If you have mixed connective tissue disease, youll likely need prescription medications to manage your symptoms. But you can also take steps to manage the disease on your own by: […] Taking nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs like ibuprofen (Advil or Motrin) and naproxen (Aleve), can help with mild pain and inflammation. […] Protecting your hands from the cold. Wear gloves in cold weather and do what you can to keep your hands warm to prevent Raynauds phenomenon.

• #45 Mixed Connective Tissue Disease: Symptoms, Causes, and Treatment

  https://www.healthline.com/health/mixed-connective-tissue-disease

  Corticosteroids. Steroid medications, such as prednisone, can treat inflammation and help stop your immune system from attacking healthy tissues. […] Antimalarial drugs. Hydroxychloroquine (Plaquenil) can help with mild MCTD and probably help prevent flare-ups. […] Calcium channel blockers. Medications such as nifedipine (Procardia) and amlodipine (Norvasc) help manage Raynauds phenomenon. […] Immunosuppressants. Severe MCTD may require long-term treatment with immunosuppressants, which are drugs that suppress your immune system. […] Pulmonary hypertension drugs. Pulmonary hypertension is the leading cause of death among people with MCTD. […] In addition to medication, several lifestyle changes can also help: Get regular exercise as much as possible. […] If you smoke, try to quit.

• #46 Mixed Connective Tissue Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK542198/

  Mixed connective tissue disease is a rare autoimmune disease characterized by the presence of the anti-U1-ribonucleoprotein, Raynaud phenomenon, and features of at least 2 connective tissue diseases, including systemic lupus erythematosus, systemic sclerosis, inflammatory myositis, and rheumatoid arthritis. […] Nonsteroidal anti-inflammatory drugs, steroids, and immunosuppressive agents are the mainstays of treatment. […] The main medications used to treat interstitial lung disease are mycophenolate mofetil, cyclophosphamide, and rituximab, with mycophenolate mofetil being the preferred initial therapy due to its comparable efficacy and fewer adverse effects compared to cyclophosphamide. […] Pulmonary hypertension is typically less responsive to steroids, and the guidance of an expert in pulmonary hypertension should direct advanced management.

• #47 Mixed Connective Tissue Disease | Treatment & Management | Point of Care

  https://www.statpearls.com/point-of-care/25207

  Due to the rarity of the condition, there are no randomized controlled trials to guide the treatment of patients with MCTD. Therapy’s general goals are to control symptoms and are directed by clinical manifestations and organ involvement. […] The main medications used to treat interstitial lung disease are mycophenolate mofetil, cyclophosphamide, and rituximab, with mycophenolate mofetil being the preferred initial therapy due to its comparable efficacy and fewer adverse effects compared to cyclophosphamide. […] Pulmonary hypertension is typically less responsive to steroids, and the guidance of an expert in pulmonary hypertension should direct advanced management. Vasodilators such as prostaglandins, including epoprostenol; endothelin receptor antagonists, including ambrisentan; phosphodiesterase 5 inhibitors, including sildenafil; and immunosuppression with corticosteroids and cyclophosphamide may be appropriate therapeutic considerations.

• #48 Mixed Connective-Tissue Disease (MCTD) Medication: Nonsteroidal anti-inflammatory drugs (NSAIDs), Proton pump inhibitors, Antimalarial agents, Corticosteroids, Phosphodiesterase (type 5) enzyme inhibitor, Endothelin receptor antagonists, Prostaglandins, I

  https://emedicine.medscape.com/article/335815-medication

  Therapeutic options in mixed connective-tissue disease (MCTD) include the following: […] Arthritis/arthralgia can often be controlled with nonsteroidal anti-inflammatory drugs (NSAIDs); antimalarials (hydroxychloroquine); and, if needed, infrequent oral or intra-articular corticosteroid courses, typically at low dose. […] Disease-modifying antirheumatic drug (DMARD) therapy is reserved for more refractory synovitis, particularly if showing features of erosive/deforming risk. […] In patients with Raynaud phenomenon, calcium channel blockers are used. […] Phosphodiesterase inhibitors, endothelin receptor antagonists, or prostaglandins can be used for pulmonary hypertension. […] In some cases, pulmonary hypertension in MCTD may also respond to aggressive immunosuppression, similar to that used in interstitial lung disease therapy.

• #49 Mixed Connective-Tissue Disease (MCTD) Treatment & Management: Approach Considerations, Consultations, Diet and Activity

  https://emedicine.medscape.com/article/335815-treatment

  Patients with stable disease and no recent changes in medications should be seen approximately every 2-4 months and undergo routine laboratory evaluation, including a complete blood cell count and chemistry studies. Patients with active disease are typically seen approximately every 3-6 weeks, depending on the severity of disease. […] Recommendations for screening and early detection of pulmonary artery hypertension (PAH) associated with connective tissue diseases, including MCTD, have been published by the Scleroderma Foundation and Pulmonary Hypertension Association. […] Use of 6-minute walk stress echocardiography has also been proposed as a means of predicting the development of PAH in patients with connective tissue disorders. […] Abnormalities on noninvasive tests require confirmation with right heart catheterization, which remains the gold standard for diagnosis of PAH.

• #50 Mixed Connective-Tissue Disease (MCTD) Treatment & Management: Approach Considerations, Consultations, Diet and Activity

  https://emedicine.medscape.com/article/335815-treatment

  Patients with stable disease and no recent changes in medications should be seen approximately every 2-4 months and undergo routine laboratory evaluation, including a complete blood cell count and chemistry studies. Patients with active disease are typically seen approximately every 3-6 weeks, depending on the severity of disease. […] Recommendations for screening and early detection of pulmonary artery hypertension (PAH) associated with connective tissue diseases, including MCTD, have been published by the Scleroderma Foundation and Pulmonary Hypertension Association. […] Use of 6-minute walk stress echocardiography has also been proposed as a means of predicting the development of PAH in patients with connective tissue disorders. […] Abnormalities on noninvasive tests require confirmation with right heart catheterization, which remains the gold standard for diagnosis of PAH.

• #51 Mixed Connective-Tissue Disease (MCTD) Medication: Nonsteroidal anti-inflammatory drugs (NSAIDs), Proton pump inhibitors, Antimalarial agents, Corticosteroids, Phosphodiesterase (type 5) enzyme inhibitor, Endothelin receptor antagonists, Prostaglandins, I

  https://emedicine.medscape.com/article/335815-medication

  Therapeutic options in mixed connective-tissue disease (MCTD) include the following: […] Arthritis/arthralgia can often be controlled with nonsteroidal anti-inflammatory drugs (NSAIDs); antimalarials (hydroxychloroquine); and, if needed, infrequent oral or intra-articular corticosteroid courses, typically at low dose. […] Disease-modifying antirheumatic drug (DMARD) therapy is reserved for more refractory synovitis, particularly if showing features of erosive/deforming risk. […] In patients with Raynaud phenomenon, calcium channel blockers are used. […] Phosphodiesterase inhibitors, endothelin receptor antagonists, or prostaglandins can be used for pulmonary hypertension. […] In some cases, pulmonary hypertension in MCTD may also respond to aggressive immunosuppression, similar to that used in interstitial lung disease therapy.

• #52 Mixed Connective Tissue Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK542198/

  The management of Raynaud phenomenon includes symptomatic strategies such as avoiding caffeine, smoking, cold temperatures, and injury to the digits. […] Arthritis and arthralgia typically respond to nonsteroidal anti-inflammatory drugs and hydroxychloroquine. […] Pleuritis, pericarditis, myositis, and aseptic meningitis typically respond to steroids. […] Gastrointestinal reflux treatment involves proton pump inhibitors (PPI) or histamine blockers, lifestyle changes, and dietary modifications, such as elevating the head of the bed and avoiding dietary triggers. […] Patients with autoimmune hemolytic anemia and thrombocytopenia are initially treated with steroids.

• #53 Mixed Connective Tissue Disease | Treatment & Management | Point of Care

  https://www.statpearls.com/point-of-care/25207

  The management of Raynaud phenomenon includes symptomatic strategies such as avoiding caffeine, smoking, cold temperatures, and injury to the digits. Oral calcium channel blockers, such as nifedipine, which decreases peripheral resistance, are an option. […] Arthritis and arthralgia typically respond to nonsteroidal anti-inflammatory drugs and hydroxychloroquine. For refractory synovitis, corticosteroids, methotrexate, and other disease-modifying anti-rheumatic drugs can be used. […] Pleuritis, pericarditis, myositis, and aseptic meningitis typically respond to steroids. Steroid-sparing agents, such as methotrexate, cyclosporine, azathioprine, and mycophenolate mofetil, are commonly used as second-line agents. […] Patients with autoimmune hemolytic anemia and thrombocytopenia are initially treated with steroids. Clinicians can consider rituximab in resistant cases.

• #54 Mixed Connective-Tissue Disease (MCTD) Medication: Nonsteroidal anti-inflammatory drugs (NSAIDs), Proton pump inhibitors, Antimalarial agents, Corticosteroids, Phosphodiesterase (type 5) enzyme inhibitor, Endothelin receptor antagonists, Prostaglandins, I

  https://emedicine.medscape.com/article/335815-medication

  Therapeutic options in mixed connective-tissue disease (MCTD) include the following: […] Arthritis/arthralgia can often be controlled with nonsteroidal anti-inflammatory drugs (NSAIDs); antimalarials (hydroxychloroquine); and, if needed, infrequent oral or intra-articular corticosteroid courses, typically at low dose. […] Disease-modifying antirheumatic drug (DMARD) therapy is reserved for more refractory synovitis, particularly if showing features of erosive/deforming risk. […] In patients with Raynaud phenomenon, calcium channel blockers are used. […] Phosphodiesterase inhibitors, endothelin receptor antagonists, or prostaglandins can be used for pulmonary hypertension. […] In some cases, pulmonary hypertension in MCTD may also respond to aggressive immunosuppression, similar to that used in interstitial lung disease therapy.

• #55 Mixed Connective Tissue Disease | Treatment & Management | Point of Care

  https://www.statpearls.com/point-of-care/25207

  The management of Raynaud phenomenon includes symptomatic strategies such as avoiding caffeine, smoking, cold temperatures, and injury to the digits. Oral calcium channel blockers, such as nifedipine, which decreases peripheral resistance, are an option. […] Arthritis and arthralgia typically respond to nonsteroidal anti-inflammatory drugs and hydroxychloroquine. For refractory synovitis, corticosteroids, methotrexate, and other disease-modifying anti-rheumatic drugs can be used. […] Pleuritis, pericarditis, myositis, and aseptic meningitis typically respond to steroids. Steroid-sparing agents, such as methotrexate, cyclosporine, azathioprine, and mycophenolate mofetil, are commonly used as second-line agents. […] Patients with autoimmune hemolytic anemia and thrombocytopenia are initially treated with steroids. Clinicians can consider rituximab in resistant cases.

• #56 Mixed Connective-Tissue Disease (MCTD) Medication: Nonsteroidal anti-inflammatory drugs (NSAIDs), Proton pump inhibitors, Antimalarial agents, Corticosteroids, Phosphodiesterase (type 5) enzyme inhibitor, Endothelin receptor antagonists, Prostaglandins, I

  https://emedicine.medscape.com/article/335815-medication

  Therapeutic options in mixed connective-tissue disease (MCTD) include the following: […] Arthritis/arthralgia can often be controlled with nonsteroidal anti-inflammatory drugs (NSAIDs); antimalarials (hydroxychloroquine); and, if needed, infrequent oral or intra-articular corticosteroid courses, typically at low dose. […] Disease-modifying antirheumatic drug (DMARD) therapy is reserved for more refractory synovitis, particularly if showing features of erosive/deforming risk. […] In patients with Raynaud phenomenon, calcium channel blockers are used. […] Phosphodiesterase inhibitors, endothelin receptor antagonists, or prostaglandins can be used for pulmonary hypertension. […] In some cases, pulmonary hypertension in MCTD may also respond to aggressive immunosuppression, similar to that used in interstitial lung disease therapy.

• #57 Mixed Connective Tissue Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK542198/

  The management of Raynaud phenomenon includes symptomatic strategies such as avoiding caffeine, smoking, cold temperatures, and injury to the digits. […] Arthritis and arthralgia typically respond to nonsteroidal anti-inflammatory drugs and hydroxychloroquine. […] Pleuritis, pericarditis, myositis, and aseptic meningitis typically respond to steroids. […] Gastrointestinal reflux treatment involves proton pump inhibitors (PPI) or histamine blockers, lifestyle changes, and dietary modifications, such as elevating the head of the bed and avoiding dietary triggers. […] Patients with autoimmune hemolytic anemia and thrombocytopenia are initially treated with steroids.

• #58

  https://www.painscale.com/article/at-home-treatments-for-mixed-connective-tissue-disease-mctd

  Certain lifestyle changes can help ease the symptoms of mixed connective tissue disease: […] Regular physical activity four or five times per week improves muscle strength, decreases the risk of heart disease and reduces blood pressure. […] Stopping the habit of smoking is important. Smoking causes blood vessels to narrow, resulting in worsened symptoms of Raynauds phenomenon. Smoking also increases blood pressure. […] Eating a diet high in fiber helps keep the digestive tract healthy. Incorporating whole grains, fruits and vegetables into the diet is beneficial for individuals with MCTD. Because a diet high in salt contributes to high blood pressure, limiting salt intake is crucial. […] Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or naproxen, can ease pain and inflammation associated with mild MCTD.

• #59

  https://www.amerikanhastanesi.org/mayo-clinic-care-network/mayo-clinic-health-information-library/diseases-conditions/mixed-connective-tissue-disease

  Other immunosuppressants. Your doctor might prescribe other medications based on your signs and symptoms. For example, if they’re similar to those of lupus, your doctor might recommend medications typically prescribed for people with lupus. […] Pulmonary hypertension medications. Bosentan (Tracleer) or sildenafil (Revatio, Viagra) might be prescribed. […] Other ways to control symptoms of mixed connective tissue disease include: […] Nonsteroidal anti-inflammatory drugs. These medications, such as ibuprofen (Advil, Motrin IB, others) or naproxen sodium (Aleve), might help relieve the pain and inflammation if your condition is mild. […] Protecting hands from cold. Wearing gloves and taking other measures to keep your hands warm can help prevent Raynaud’s phenomenon. […] Not smoking. Smoking causes blood vessels to narrow, which can worsen the effects of Raynaud’s phenomenon. […] Reducing stress. Raynaud’s phenomenon is often triggered by stress. Relaxation techniques such as slowing and focusing on your breathing can help reduce your stress levels.

• #60

  https://www.painscale.com/article/at-home-treatments-for-mixed-connective-tissue-disease-mctd

  Certain lifestyle changes can help ease the symptoms of mixed connective tissue disease: […] Regular physical activity four or five times per week improves muscle strength, decreases the risk of heart disease and reduces blood pressure. […] Stopping the habit of smoking is important. Smoking causes blood vessels to narrow, resulting in worsened symptoms of Raynauds phenomenon. Smoking also increases blood pressure. […] Eating a diet high in fiber helps keep the digestive tract healthy. Incorporating whole grains, fruits and vegetables into the diet is beneficial for individuals with MCTD. Because a diet high in salt contributes to high blood pressure, limiting salt intake is crucial. […] Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or naproxen, can ease pain and inflammation associated with mild MCTD.

• #61

  https://www.amerikanhastanesi.org/mayo-clinic-care-network/mayo-clinic-health-information-library/diseases-conditions/mixed-connective-tissue-disease

  Other immunosuppressants. Your doctor might prescribe other medications based on your signs and symptoms. For example, if they’re similar to those of lupus, your doctor might recommend medications typically prescribed for people with lupus. […] Pulmonary hypertension medications. Bosentan (Tracleer) or sildenafil (Revatio, Viagra) might be prescribed. […] Other ways to control symptoms of mixed connective tissue disease include: […] Nonsteroidal anti-inflammatory drugs. These medications, such as ibuprofen (Advil, Motrin IB, others) or naproxen sodium (Aleve), might help relieve the pain and inflammation if your condition is mild. […] Protecting hands from cold. Wearing gloves and taking other measures to keep your hands warm can help prevent Raynaud’s phenomenon. […] Not smoking. Smoking causes blood vessels to narrow, which can worsen the effects of Raynaud’s phenomenon. […] Reducing stress. Raynaud’s phenomenon is often triggered by stress. Relaxation techniques such as slowing and focusing on your breathing can help reduce your stress levels.

• #62

  https://www.painscale.com/article/at-home-treatments-for-mixed-connective-tissue-disease-mctd

  Reducing stress levels can help prevent symptoms of Raynauds disease, which is often triggered by stress. Practicing relaxation techniques is often beneficial. Slow, deep breathing can reduce stress levels. […] Protecting the hands from the cold can reduce flare-ups of Raynauds phenomenon associated with MCTD. Wearing gloves in cold environments can help. […] Joining a chronic illness support group, in person or online, can help individuals cope with MCTD.

• #63 Mixed Connective-Tissue Disease (MCTD) Medication: Nonsteroidal anti-inflammatory drugs (NSAIDs), Proton pump inhibitors, Antimalarial agents, Corticosteroids, Phosphodiesterase (type 5) enzyme inhibitor, Endothelin receptor antagonists, Prostaglandins, I

  https://emedicine.medscape.com/article/335815-medication

  MCTD-related interstitial lung disease (ILD) is conventionally treated with corticosteroids in combination with steroid-sparing agents such as cyclophosphamide, azathioprine, or mycophenolate. […] The RECITAL trial, which included patients with MCTD, found that rituximab was noninferior to cyclophosphamide for treatment of ILD, and was associated with fewer adverse effects. […] The INBUILD trial, which included patients with MCTD, reported that treatment with the antifibrotic tyrosine kinase inhibitor nintedanib can significantly slow the annual rate of decline in forced vital capacity (FVC) in patients with progressive fibrosing ILDs. […] DMARDs used in the management of rheumatoid arthritis can be relevant in MCTD, in which a significant subset of patients have clinical manifestations that include those of chronic erosive polyarthritis, as is seen in rheumatoid arthritis. […] Increasingly, targeted therapies effective against other rheumatic diseases are emerging that may find a place in therapy for the overlapping rheumatic features in MCTD patients. A notable example is belimumab, a B-cell survival inhibitor that is approved for use in lupus.

• #64 Mixed Connective Tissue Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK542198/

  Mixed connective tissue disease is a rare autoimmune disease characterized by the presence of the anti-U1-ribonucleoprotein, Raynaud phenomenon, and features of at least 2 connective tissue diseases, including systemic lupus erythematosus, systemic sclerosis, inflammatory myositis, and rheumatoid arthritis. […] Nonsteroidal anti-inflammatory drugs, steroids, and immunosuppressive agents are the mainstays of treatment. […] The main medications used to treat interstitial lung disease are mycophenolate mofetil, cyclophosphamide, and rituximab, with mycophenolate mofetil being the preferred initial therapy due to its comparable efficacy and fewer adverse effects compared to cyclophosphamide. […] Pulmonary hypertension is typically less responsive to steroids, and the guidance of an expert in pulmonary hypertension should direct advanced management.

• #65 Mixed Connective-Tissue Disease (MCTD) Medication: Nonsteroidal anti-inflammatory drugs (NSAIDs), Proton pump inhibitors, Antimalarial agents, Corticosteroids, Phosphodiesterase (type 5) enzyme inhibitor, Endothelin receptor antagonists, Prostaglandins, I

  https://emedicine.medscape.com/article/335815-medication

  MCTD-related interstitial lung disease (ILD) is conventionally treated with corticosteroids in combination with steroid-sparing agents such as cyclophosphamide, azathioprine, or mycophenolate. […] The RECITAL trial, which included patients with MCTD, found that rituximab was noninferior to cyclophosphamide for treatment of ILD, and was associated with fewer adverse effects. […] The INBUILD trial, which included patients with MCTD, reported that treatment with the antifibrotic tyrosine kinase inhibitor nintedanib can significantly slow the annual rate of decline in forced vital capacity (FVC) in patients with progressive fibrosing ILDs. […] DMARDs used in the management of rheumatoid arthritis can be relevant in MCTD, in which a significant subset of patients have clinical manifestations that include those of chronic erosive polyarthritis, as is seen in rheumatoid arthritis. […] Increasingly, targeted therapies effective against other rheumatic diseases are emerging that may find a place in therapy for the overlapping rheumatic features in MCTD patients. A notable example is belimumab, a B-cell survival inhibitor that is approved for use in lupus.

• #66 Mixed Connective Tissue Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK542198/

  The management of Raynaud phenomenon includes symptomatic strategies such as avoiding caffeine, smoking, cold temperatures, and injury to the digits. […] Arthritis and arthralgia typically respond to nonsteroidal anti-inflammatory drugs and hydroxychloroquine. […] Pleuritis, pericarditis, myositis, and aseptic meningitis typically respond to steroids. […] Gastrointestinal reflux treatment involves proton pump inhibitors (PPI) or histamine blockers, lifestyle changes, and dietary modifications, such as elevating the head of the bed and avoiding dietary triggers. […] Patients with autoimmune hemolytic anemia and thrombocytopenia are initially treated with steroids.

• #67

  https://arthritis.ca/about-arthritis/arthritis-types-(a-z)/types/mixed-connective-tissue-disease-(mctd)

  In severe cases of MCTD, immunosuppressive drugs (e.g. cytotoxic drugs) may also be needed. These drugs are powerful medications that suppress inflammation and the immune system. You may be prescribed these if your MCTD symptoms are difficult to control with prednisone alone or if you are experiencing side effects from prednisone. […] Raynauds Phenomenon (fingers turning pale) may require treatment especially if it is severe and complicated by finger tip ulcers. Calcium channel blockers or PDE5 inhibitors may be used. Often proton pump inhibitors, antacids, H2 blockers and pro-motility drugs may be used for the esophageal reflux (heart burn with acid reflux) or dysphagia (problems swallowing) or other stomach/bowel symptoms. […] In general, the more advanced the disease and the greater the organ damage, the less effective the treatment will be. Scleroderma-like damage to the skin and esophagus is least likely to respond to treatment. Symptom-free periods can sometimes last for many years with minimal or no ongoing treatment. However, MCTD will progress in spite of treatment in about 13 per cent of cases. In large part, the prognosis for MCTD is usually quite good.

• #68 Mixed connective tissue disease – Wikipedia

  https://en.wikipedia.org/wiki/Mixed_connective_tissue_disease

  Traditional therapies such as calcium channel blockers, ACE inhibitors, immunosuppression, and heart failure medications can be used. […] Pericarditis is typically treated with NSAIDs and/or corticosteroids based on severity. For moderate to severe myocarditis, high-dose steroid therapy should be combined with standard congestive heart failure treatment. […] Treatment for gastrointestinal problems in MCTD is identical to that for systemic sclerosis. First-line treatment for chronic reflux symptoms includes proton-pump inhibitors, H2-receptor antagonists, lifestyle changes, and oesophageal PH monitoring. […] Kidney involvement can lead to nephrotic syndrome, which may be treated with high-dose corticosteroid therapy. Corticosteroids are used to treat nervous system involvement in low-dose oral, high-dose oral, or high-dose intravenous regimens, depending on the severity of the potential harm.

• #69 Mixed connective tissue disease – Wikipedia

  https://en.wikipedia.org/wiki/Mixed_connective_tissue_disease

  Traditional therapies such as calcium channel blockers, ACE inhibitors, immunosuppression, and heart failure medications can be used. […] Pericarditis is typically treated with NSAIDs and/or corticosteroids based on severity. For moderate to severe myocarditis, high-dose steroid therapy should be combined with standard congestive heart failure treatment. […] Treatment for gastrointestinal problems in MCTD is identical to that for systemic sclerosis. First-line treatment for chronic reflux symptoms includes proton-pump inhibitors, H2-receptor antagonists, lifestyle changes, and oesophageal PH monitoring. […] Kidney involvement can lead to nephrotic syndrome, which may be treated with high-dose corticosteroid therapy. Corticosteroids are used to treat nervous system involvement in low-dose oral, high-dose oral, or high-dose intravenous regimens, depending on the severity of the potential harm.

• #70

  https://www.painscale.com/article/at-home-treatments-for-mixed-connective-tissue-disease-mctd

  Certain lifestyle changes can help ease the symptoms of mixed connective tissue disease: […] Regular physical activity four or five times per week improves muscle strength, decreases the risk of heart disease and reduces blood pressure. […] Stopping the habit of smoking is important. Smoking causes blood vessels to narrow, resulting in worsened symptoms of Raynauds phenomenon. Smoking also increases blood pressure. […] Eating a diet high in fiber helps keep the digestive tract healthy. Incorporating whole grains, fruits and vegetables into the diet is beneficial for individuals with MCTD. Because a diet high in salt contributes to high blood pressure, limiting salt intake is crucial. […] Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or naproxen, can ease pain and inflammation associated with mild MCTD.

• #71 Mixed Connective Tissue Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK542198/

  The management of Raynaud phenomenon includes symptomatic strategies such as avoiding caffeine, smoking, cold temperatures, and injury to the digits. […] Arthritis and arthralgia typically respond to nonsteroidal anti-inflammatory drugs and hydroxychloroquine. […] Pleuritis, pericarditis, myositis, and aseptic meningitis typically respond to steroids. […] Gastrointestinal reflux treatment involves proton pump inhibitors (PPI) or histamine blockers, lifestyle changes, and dietary modifications, such as elevating the head of the bed and avoiding dietary triggers. […] Patients with autoimmune hemolytic anemia and thrombocytopenia are initially treated with steroids.

• #72 Mixed connective tissue disease – Wikipedia

  https://en.wikipedia.org/wiki/Mixed_connective_tissue_disease

  High dosages of corticosteroids are typically effective in treating acute severe myositis. […] Topical steroids, prednisone, and/or hydroxychloroquine are useful in treating SLE-like skin rash, oral ulcers, and photosensitivity. […] Steroid treatment is often effective in treating sclerodermatous skin symptoms. Raynaud’s phenomenon in MCTD typically responds to vasodilator therapy such as calcium channel blockers, as well as preventive measures including avoiding cold temperatures, smoking, and sympathomimetic drugs. Warming and protecting the fingers are also important. […] Recent breakthroughs have increased the therapy choices available to people with pulmonary hypertension. […] To ensure early detection, all individuals with MCTD must have screening echocardiography and high-resolution computed tomography upon diagnosis. Mild cases require regular testing to monitor for progression.

• #73 Mixed Connective Tissue Disease | Treatment & Management | Point of Care

  https://www.statpearls.com/point-of-care/25207

  The management of Raynaud phenomenon includes symptomatic strategies such as avoiding caffeine, smoking, cold temperatures, and injury to the digits. Oral calcium channel blockers, such as nifedipine, which decreases peripheral resistance, are an option. […] Arthritis and arthralgia typically respond to nonsteroidal anti-inflammatory drugs and hydroxychloroquine. For refractory synovitis, corticosteroids, methotrexate, and other disease-modifying anti-rheumatic drugs can be used. […] Pleuritis, pericarditis, myositis, and aseptic meningitis typically respond to steroids. Steroid-sparing agents, such as methotrexate, cyclosporine, azathioprine, and mycophenolate mofetil, are commonly used as second-line agents. […] Patients with autoimmune hemolytic anemia and thrombocytopenia are initially treated with steroids. Clinicians can consider rituximab in resistant cases.

• #74 Tocilizumab in the treatment of mixed connective tissue disease and overlap syndrome in children | RMD Open

  https://rmdopen.bmj.com/content/2/2/e000271

  Arthritis is one of the main manifestations of mixed connective tissue disease (MCTD) and overlap syndrome in children and can be responsible for functional disability. We report on 2 children with arthritis that were dramatically improved by a treatment with interleukin-6 (IL-6) blockers in the context of connective tissue disease. […] Here we report on the dual effect of tocilizumab on systemic symptoms in the context of pediatric-onset mixed connectivitis. Refractory arthritis was very sensitive to IL-6 blockade, while the other lupus-like systemic symptoms were not modified and even possibly increased. […] In the context of systemic autoimmunity, treating arthritis is sometimes challenging. Il-6 blockers may represent a promising option but a cautious follow-up of other systemic manifestations and autoantibodies is mandatory.

• #75 Tocilizumab in the treatment of mixed connective tissue disease and overlap syndrome in children | RMD Open

  https://rmdopen.bmj.com/content/2/2/e000271

  The treatment is challenging and relies on non-steroidal anti-inflammatory drugs, corticosteroids (CTC), immunosuppressive and/or hydroxychloroquine (HCQ). […] Here, we report on two children with pMCTD with refractory arthritis who were successfully treated with tocilizumab (TCZ). However, TCZ was ineffective on systemic symptoms in both patients. […] In both cases, TCZ was effective in the treatment of arthritis. […] These two observations suggest that TCZ may be effective to treat joint manifestations in the context of MCTD/overlap syndrome but systemic autoimmunity does not seem to be prevented.

• #76 Tocilizumab for the treatment of refractory pediatric mixed connective tissue disease (MCTD), in two patients | Pediatric Rheumatology | Full Text

  https://ped-rheum.biomedcentral.com/articles/10.1186/1546-0096-12-S1-P303

  Mixed Connective Tissue Disease (MCTD) is a rare autoimmune disease of unknown origin. Treatment should be tailored to the clinical symptoms but no specific recommendation regarding the therapeutic management has been established to date. […] Tocilizumab (TCZ) is as a therapeutic option in the MCTD with polyarticular manifestations refractory or intolerant to basic treatment. […] This is the first description of the use of TCZ for articular manifestations of pediatric-onset MCTD. These two observations suggest that TCZ is effective and safe on articular manifestations of MCTD. However, systemic autoimmune manifestations including leucopenia and hepatitis were not improved by the treatment.

• #77 Mixed Connective Tissue Disease (MCTD): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15039-mixed-connective-tissue-disease

  Other immunosuppressants. If major organs are affected, you may need to take other immunosuppressants to suppress the actions of your immune system. […] Antihypertensive medications. Your provider may prescribe blood pressure medications to treat pulmonary hypertension. Pulmonary hypertension can lead to heart failure and many other serious complications. Its the most common cause of death in people with MCTD. […] If you have mixed connective tissue disease, youll likely need prescription medications to manage your symptoms. But you can also take steps to manage the disease on your own by: […] Taking nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs like ibuprofen (Advil or Motrin) and naproxen (Aleve), can help with mild pain and inflammation. […] Protecting your hands from the cold. Wear gloves in cold weather and do what you can to keep your hands warm to prevent Raynauds phenomenon.

• #78 Mixed Connective Tissue Disease: Symptoms, Causes, and Treatment

  https://www.healthline.com/health/mixed-connective-tissue-disease

  Corticosteroids. Steroid medications, such as prednisone, can treat inflammation and help stop your immune system from attacking healthy tissues. […] Antimalarial drugs. Hydroxychloroquine (Plaquenil) can help with mild MCTD and probably help prevent flare-ups. […] Calcium channel blockers. Medications such as nifedipine (Procardia) and amlodipine (Norvasc) help manage Raynauds phenomenon. […] Immunosuppressants. Severe MCTD may require long-term treatment with immunosuppressants, which are drugs that suppress your immune system. […] Pulmonary hypertension drugs. Pulmonary hypertension is the leading cause of death among people with MCTD. […] In addition to medication, several lifestyle changes can also help: Get regular exercise as much as possible. […] If you smoke, try to quit.

• #79

  https://www.amerikanhastanesi.org/mayo-clinic-care-network/mayo-clinic-health-information-library/diseases-conditions/mixed-connective-tissue-disease

  Other immunosuppressants. Your doctor might prescribe other medications based on your signs and symptoms. For example, if they’re similar to those of lupus, your doctor might recommend medications typically prescribed for people with lupus. […] Pulmonary hypertension medications. Bosentan (Tracleer) or sildenafil (Revatio, Viagra) might be prescribed. […] Other ways to control symptoms of mixed connective tissue disease include: […] Nonsteroidal anti-inflammatory drugs. These medications, such as ibuprofen (Advil, Motrin IB, others) or naproxen sodium (Aleve), might help relieve the pain and inflammation if your condition is mild. […] Protecting hands from cold. Wearing gloves and taking other measures to keep your hands warm can help prevent Raynaud’s phenomenon. […] Not smoking. Smoking causes blood vessels to narrow, which can worsen the effects of Raynaud’s phenomenon. […] Reducing stress. Raynaud’s phenomenon is often triggered by stress. Relaxation techniques such as slowing and focusing on your breathing can help reduce your stress levels.

• #80 Mixed Connective-Tissue Disease (MCTD) Treatment & Management: Approach Considerations, Consultations, Diet and Activity

  https://emedicine.medscape.com/article/335815-treatment

  Patients with MCTD that involves esophageal reflux, malabsorption, or other sclerodermatous-type bowel involvement may need special consideration with respect to diet. […] High-dose omega-3 fatty acids have been reported to inhibit the production of pro-inflammatory prostaglandins, and clinical trials have reported benefits of dietary supplementation with omega-3 fatty acids in several inflammatory and autoimmune diseases. […] Convincing data support the value of an active lifestyle and an exercise program tailored to the needs of patients with arthritis of various types. […] Given that other inflammatory rheumatic diseases are reported to be independent risk factors for the development of atherosclerosis and related conditions, patients with MCTD may also be at increased risk for atherosclerosis.

• #81 Mixed Connective-Tissue Disease (MCTD) Treatment & Management: Approach Considerations, Consultations, Diet and Activity

  https://emedicine.medscape.com/article/335815-treatment

  Patients with MCTD that involves esophageal reflux, malabsorption, or other sclerodermatous-type bowel involvement may need special consideration with respect to diet. […] High-dose omega-3 fatty acids have been reported to inhibit the production of pro-inflammatory prostaglandins, and clinical trials have reported benefits of dietary supplementation with omega-3 fatty acids in several inflammatory and autoimmune diseases. […] Convincing data support the value of an active lifestyle and an exercise program tailored to the needs of patients with arthritis of various types. […] Given that other inflammatory rheumatic diseases are reported to be independent risk factors for the development of atherosclerosis and related conditions, patients with MCTD may also be at increased risk for atherosclerosis.

• #82 Mixed Connective Tissue Disease and Diet

  https://www.verywellhealth.com/what-to-eat-when-you-have-mixed-connective-tissue-disease-5097156

  Anti-inflammatory medications are a cornerstone of treatment for mixed connective tissue disease (MCTD) but your diet also is important. Eating a healthy, balanced diet may help prevent flare-ups caused by MCTD, which has overlapping features of a few autoimmune conditions. […] Be sure to talk with your provider about how food choices (including supplements) might offer benefits in managing MCTD. […] An MCTD diet is part of an overall strategy for managing MCTD. Regular physical activity, maintaining a healthy weight, reducing stress, and getting enough sleep can help your body deal with symptoms. […] Look for foods that lower inflammation and balance gut bacteria: fresh fruits, vegetables, fiber, omega-3 fatty acids, and prebiotics may be the most helpful. Avoid highly processed foods, and foods high in sodium and sugar. It may help to cook your meals at home. […] Always involve your healthcare provider(s) in choices about diet and supplements. They can steer you away from selections that may affect your disease. You may also benefit from seeking advice from a dietitian.

• #83 Mixed Connective Tissue Disease Treatment | Atlanta

  https://argmd.net/conditions-we-treat/mixed-connective-tissue-disease-mctd/

  Medications: […] Corticosteroids: To reduce inflammation and control acute flare-ups. […] Immunosuppressive Drugs: Such as methotrexate, azathioprine, or mycophenolate mofetil to control the immune system. […] NSAIDs: Nonsteroidal anti-inflammatory drugs to relieve pain and reduce inflammation. […] Calcium Channel Blockers: To manage Raynauds phenomenon. […] […] […] Therapies: […] Physical Therapy: Exercises to improve muscle strength and flexibility. […] Occupational Therapy: Techniques to perform daily activities safely and efficiently. […] Speech Therapy: For patients experiencing difficulty swallowing. […] […] […] Lifestyle Changes: […] Regular Exercise: Engaging in low-impact exercises such as swimming or walking to maintain muscle strength.

• #84

  https://arthritis.ca/about-arthritis/arthritis-types-(a-z)/types/mixed-connective-tissue-disease-(mctd)

  The optimal treatment is what is best in each individual case so speak with your specialist about what kind of medications are most appropriate for you for several features of the disease. […] A physiotherapist (PT) can develop an individualized program designed to help you increase your strength, flexibility, range-of-motion, and general mobility and exercise tolerance through a wide variety of therapeutic treatments and strategies. […] An occupational therapist (OT) trained in arthritis management can analyze everything you do in a day and develop a program to help you protect your joints and minimize fatigue. […] In addition to following your treatment plan, there is a lot you can do yourself to help decrease your pain and increase your movement. Physiotherapy, occupational therapy, regular exercise and relaxation techniques are very important parts of your overall treatment plan.

• #85 Understanding Connective Tissue Diseases: Symptoms, Risks, and Treatment

  https://www.rupahealth.com/post/understanding-connective-tissue-diseases-symptoms-risks-and-treatment

  Managing connective tissue diseases (CTDs) involves a multifaceted approach, combining medication, lifestyle changes, and supportive therapies. […] Medications used for the treatment of CTDs include: […] Disease-modifying anti-rheumatic drugs (DMARDs) and biologics are crucial for long-term management of CTDs. […] Immunosuppressants: In severe cases, immunosuppressants such as azathioprine or cyclophosphamide may be prescribed to control the immune system’s activity, preventing it from attacking healthy tissues. […] A balanced diet rich in anti-inflammatory foods like fruits, vegetables, omega-3 fatty acids, and whole grains can help manage symptoms. […] Regular, low-impact exercise like swimming, walking, or yoga is vital for maintaining joint mobility and overall health. […] Stress reduction techniques, including meditation, deep breathing exercises, and mindfulness, can significantly benefit patients with CTDs.

• #86 Understanding Connective Tissue Diseases: Symptoms, Risks, and Treatment

  https://www.rupahealth.com/post/understanding-connective-tissue-diseases-symptoms-risks-and-treatment

  Physical therapy plays a key role in maintaining function and mobility for patients with CTDs. […] Occupational therapy helps patients manage daily activities and maintain independence. […] A comprehensive, multi-disciplinary approach to managing connective tissue diseases improves long-term patient outcomes. […] Effective management of CTDs through early detection, ongoing care, and a proactive approach can improve patient’s quality of life and reduce the risk of severe complications.

• #87 Mixed Connective-Tissue Disease (MCTD) Treatment & Management: Approach Considerations, Consultations, Diet and Activity

  https://emedicine.medscape.com/article/335815-treatment

  Patients with stable disease and no recent changes in medications should be seen approximately every 2-4 months and undergo routine laboratory evaluation, including a complete blood cell count and chemistry studies. Patients with active disease are typically seen approximately every 3-6 weeks, depending on the severity of disease. […] Recommendations for screening and early detection of pulmonary artery hypertension (PAH) associated with connective tissue diseases, including MCTD, have been published by the Scleroderma Foundation and Pulmonary Hypertension Association. […] Use of 6-minute walk stress echocardiography has also been proposed as a means of predicting the development of PAH in patients with connective tissue disorders. […] Abnormalities on noninvasive tests require confirmation with right heart catheterization, which remains the gold standard for diagnosis of PAH.

• #88 Mixed Connective Tissue Disease | Riley Children’s Health

  https://www.rileychildrens.org/health-info/mixed-connective-tissue-disease

  A child with MCTD needs to be seen by his or her rheumatologist about every three to six months to monitor the disease and reassess the treatment regimen. […] Researchers have not yet discovered a cure for this disorder. Your child’s doctor will likely prescribe a combination of medicines to control symptoms and flare-ups.

• #89 Mixed Connective Tissue Disease (MCTD) – Bone, Joint, and Muscle Disorders – Merck Manual Consumer Version

  https://www.merckmanuals.com/home/bone-joint-and-muscle-disorders/systemic-rheumatic-diseases/mixed-connective-tissue-disease-mctd

  People who develop myositis or systemic sclerosis are treated for those diseases based on their symptoms. People who have Raynaud syndrome are treated based on their symptoms and may be given a calcium channel blocker (such as nifedipine) and medications that increase blood flow (such as sildenafil or tadalafil). […] People who take corticosteroids are at risk of fractures related to osteoporosis. To prevent osteoporosis, these people are given the medications used to treat osteoporosis, such as bisphosphonates and supplements of vitamin D and calcium. […] People who are receiving immunosuppressants are also given medications to prevent infections such as by the fungus Pneumocystis jirovecii and vaccines against common infections such as pneumonia, influenza, and COVID-19. […] Doctors monitor people with mixed connective tissue disease for pulmonary hypertension by doing pulmonary function testing, echocardiography, or both every 1 to 2 years, depending on symptoms.

• #90 Mixed Connective Tissue Disease (MCTD) – Musculoskeletal and Connective Tissue Disorders – MSD Manual Professional Edition

  https://www.msdmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/systemic-rheumatic-diseases/mixed-connective-tissue-disease-mctd

  Most patients with moderate or severe disease respond to corticosteroids, particularly if treated early; however, corticosteroid use should be minimized when findings of systemic sclerosis are marked to avoid scleroderma renal crisis. […] Severe major organ involvement usually requires higher doses of corticosteroids (eg, oral prednisone 1 mg/kg once a day) and additional immunosuppressants. […] Patients with Raynaud syndrome should be treated based on their symptoms and as tolerated by their blood pressure with calcium channel blockers (eg, nifedipine) and phosphodiesterase inhibitors (eg, tadalafil). […] All patients should be closely monitored for atherosclerosis. Patients on long-term corticosteroid therapy should receive osteoporosis prophylaxis. […] If combination immunosuppressive therapy is used, patients should be given prophylaxis for opportunistic infections, such as Pneumocystis jirovecii, and vaccines against common infections (eg, streptococcal pneumonia, influenza, COVID-19). […] Some experts encourage screening for pulmonary hypertension on a periodic basis with pulmonary function testing and/or echocardiography every 1 to 2 years, depending on symptoms.

• #91 Mixed Connective-Tissue Disease (MCTD) Treatment & Management: Approach Considerations, Consultations, Diet and Activity

  https://emedicine.medscape.com/article/335815-treatment

  Patients with MCTD that involves esophageal reflux, malabsorption, or other sclerodermatous-type bowel involvement may need special consideration with respect to diet. […] High-dose omega-3 fatty acids have been reported to inhibit the production of pro-inflammatory prostaglandins, and clinical trials have reported benefits of dietary supplementation with omega-3 fatty acids in several inflammatory and autoimmune diseases. […] Convincing data support the value of an active lifestyle and an exercise program tailored to the needs of patients with arthritis of various types. […] Given that other inflammatory rheumatic diseases are reported to be independent risk factors for the development of atherosclerosis and related conditions, patients with MCTD may also be at increased risk for atherosclerosis.

• #92 Mixed Connective Tissue Disease (MCTD) – Musculoskeletal and Connective Tissue Disorders – MSD Manual Professional Edition

  https://www.msdmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/systemic-rheumatic-diseases/mixed-connective-tissue-disease-mctd

  Most patients with moderate or severe disease respond to corticosteroids, particularly if treated early; however, corticosteroid use should be minimized when findings of systemic sclerosis are marked to avoid scleroderma renal crisis. […] Severe major organ involvement usually requires higher doses of corticosteroids (eg, oral prednisone 1 mg/kg once a day) and additional immunosuppressants. […] Patients with Raynaud syndrome should be treated based on their symptoms and as tolerated by their blood pressure with calcium channel blockers (eg, nifedipine) and phosphodiesterase inhibitors (eg, tadalafil). […] All patients should be closely monitored for atherosclerosis. Patients on long-term corticosteroid therapy should receive osteoporosis prophylaxis. […] If combination immunosuppressive therapy is used, patients should be given prophylaxis for opportunistic infections, such as Pneumocystis jirovecii, and vaccines against common infections (eg, streptococcal pneumonia, influenza, COVID-19). […] Some experts encourage screening for pulmonary hypertension on a periodic basis with pulmonary function testing and/or echocardiography every 1 to 2 years, depending on symptoms.

• #93 Mixed Connective Tissue Disease (MCTD): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15039-mixed-connective-tissue-disease

  Quitting smoking. Smoking narrows your blood vessels, which makes the effects of Raynauds phenomenon worse. […] Reducing stress. Stress can trigger Raynauds phenomenon. Reduce your stress levels and practice relaxation techniques. Mental healthcare can also help you cope with stress. […] Long-term corticosteroid use can lead to side effects like: […] Bone loss due to osteoporosis […] Tissue death due to lack of blood flow (ischemia) […] Muscle weakness […] Infections […] Cushing syndrome. […] You must see your healthcare provider on a regular basis to monitor and control these possible effects. […] People who have a long-term, incurable condition like MCTD should develop ways of dealing with their disease. This includes: […] Seeking advice from your primary care provider.

• #94 Mixed Connective Tissue Disease (MCTD): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15039-mixed-connective-tissue-disease

  Consulting with a mental health professional for conditions like depression and anxiety. […] Following proper healthy eating and physical activity plans (if not overly fatigued). […] Learning as much as possible about the disease. […] Joining a chronic illness support group. […] What treatments are available for my condition? […] How can I prevent flare-ups?

• #95

  https://arthritis.ca/about-arthritis/arthritis-types-(a-z)/types/mixed-connective-tissue-disease-(mctd)

  The optimal treatment is what is best in each individual case so speak with your specialist about what kind of medications are most appropriate for you for several features of the disease. […] A physiotherapist (PT) can develop an individualized program designed to help you increase your strength, flexibility, range-of-motion, and general mobility and exercise tolerance through a wide variety of therapeutic treatments and strategies. […] An occupational therapist (OT) trained in arthritis management can analyze everything you do in a day and develop a program to help you protect your joints and minimize fatigue. […] In addition to following your treatment plan, there is a lot you can do yourself to help decrease your pain and increase your movement. Physiotherapy, occupational therapy, regular exercise and relaxation techniques are very important parts of your overall treatment plan.

• #96

  https://arthritis.ca/about-arthritis/arthritis-types-(a-z)/types/mixed-connective-tissue-disease-(mctd)

  Exercise is physical activity that involves heavier, repetitive exertion, and is designed to improve or maintain physical fitness. […] Many low-impact exercise options can benefit people living with arthritis. Consult your health-care provider to find an exercise(s) that is suitable to you and your particular condition. […] Techniques to protect your joints include: Pace yourself: alternate heavy or repeated tasks with lighter tasks. […] Taking a warm shower and using warm packs are great ways to help reduce pain and stiffness. […] There is no conclusive evidence to suggest that what you eat can make arthritis either better or worse. However, being overweight can put excess strain on your joints. […] Developing good relaxation and coping skills can help you maintain balance in your life, giving you a greater feeling of control over your arthritis and a more positive outlook. […] People with a chronic disease like arthritis may decide to try complementary or alternative therapies to help them manage the symptoms of their condition.

• #97

  https://arthritis.ca/about-arthritis/arthritis-types-(a-z)/types/mixed-connective-tissue-disease-(mctd)

  Exercise is physical activity that involves heavier, repetitive exertion, and is designed to improve or maintain physical fitness. […] Many low-impact exercise options can benefit people living with arthritis. Consult your health-care provider to find an exercise(s) that is suitable to you and your particular condition. […] Techniques to protect your joints include: Pace yourself: alternate heavy or repeated tasks with lighter tasks. […] Taking a warm shower and using warm packs are great ways to help reduce pain and stiffness. […] There is no conclusive evidence to suggest that what you eat can make arthritis either better or worse. However, being overweight can put excess strain on your joints. […] Developing good relaxation and coping skills can help you maintain balance in your life, giving you a greater feeling of control over your arthritis and a more positive outlook. […] People with a chronic disease like arthritis may decide to try complementary or alternative therapies to help them manage the symptoms of their condition.

• #98 Mixed connective tissue disease: state of the art on clinical practice guidelines | RMD Open

  https://rmdopen.bmj.com/content/4/Suppl_1/e000783

  Although there was no specific CPG on MCTD, the ERN-ReCONNET MCTD group selected five references that could be used in the context of MCTD. […] To improve management, it would certainly be helpful to develop and validate a (composite) disease activity score for MCTD that takes into account all relevant signs and symptoms. […] The worst prognosis and high mortality are associated with the presence of pulmonary disease. […] There is no agreement about the initial or long-term treatment of MCTD, especially on the usefulness of low-dose glucocorticoids, antimalaria and immunosuppressive therapies in various clinical situations. […] Overall, the ERN-ReCONNET MCTD group agrees on the need for evidence-based CPGs on MCTD treatment. […] Last but not the least, CPGs on MCTD should also take into account patients point of view in order to improve patients daily quality of care and life. […] Treatment options are limited to hydroxychloroquine, corticosteroids and immunosuppressive drugs, so there is also a need for alternative treatments with less side effects. […] Further CPGs should focus on MCTD diagnosis, evaluations, treatment and patients needs.

• #99 Mixed Connective Tissue Disease: Coping, Support, and Living Well

  https://www.verywellhealth.com/mixed-connective-tissue-disease-coping-5104817

  While there is no cure for MCTD, there are things you can do or pay attention to that can improve your quality of life. […] The goal of any treatment plan for MCTD is to minimize symptoms and their effect on your daily life. You may be prescribed medications such as hydroxychloroquine for lupus-like symptoms and arthritis-type pain, or NSAIDs like Advil for general pain. […] To help you live well with MCTD, your practitioner may also make self-care suggestions that can help you manage the disease on your own at home. Lifestyle modifications, paying attention to your diet, and getting enough exercise are all things you can do to help. […] While there is no overarching diet that has been established for MCTD, a diet that lowers inflammation in the body can be beneficial. […] Remaining active with MCTD is important to living well. Regular exercise can help with your pain and fatigue and prevent further complications.

• #100 Mixed Connective Tissue Disease: Coping, Support, and Living Well

  https://www.verywellhealth.com/mixed-connective-tissue-disease-coping-5104817

  If you have difficulty finding an exercise routine that works for you, talk to your healthcare provider. They can prescribe physical therapy and a therapist can work with you to develop a routine that benefits your body and works with your symptoms. […] One of the most important aspects of living well with MCTD is to put together a healthcare team that can oversee your well-being. […] To make sure you get the most out of your appointments with your rheumatologist and other healthcare providers you might consider keeping a symptom diary. […] If you feel that you need accommodations to perform your job, you may consider revealing your MCTD diagnosis so that you can ask for proper accommodations.

• #101 Mixed Connective Tissue Disease: Coping, Support, and Living Well

  https://www.verywellhealth.com/mixed-connective-tissue-disease-coping-5104817

  If you have difficulty finding an exercise routine that works for you, talk to your healthcare provider. They can prescribe physical therapy and a therapist can work with you to develop a routine that benefits your body and works with your symptoms. […] One of the most important aspects of living well with MCTD is to put together a healthcare team that can oversee your well-being. […] To make sure you get the most out of your appointments with your rheumatologist and other healthcare providers you might consider keeping a symptom diary. […] If you feel that you need accommodations to perform your job, you may consider revealing your MCTD diagnosis so that you can ask for proper accommodations.

• #102 Mixed connective tissue disease: state of the art on clinical practice guidelines | RMD Open

  https://rmdopen.bmj.com/content/4/Suppl_1/e000783

  Although there was no specific CPG on MCTD, the ERN-ReCONNET MCTD group selected five references that could be used in the context of MCTD. […] To improve management, it would certainly be helpful to develop and validate a (composite) disease activity score for MCTD that takes into account all relevant signs and symptoms. […] The worst prognosis and high mortality are associated with the presence of pulmonary disease. […] There is no agreement about the initial or long-term treatment of MCTD, especially on the usefulness of low-dose glucocorticoids, antimalaria and immunosuppressive therapies in various clinical situations. […] Overall, the ERN-ReCONNET MCTD group agrees on the need for evidence-based CPGs on MCTD treatment. […] Last but not the least, CPGs on MCTD should also take into account patients point of view in order to improve patients daily quality of care and life. […] Treatment options are limited to hydroxychloroquine, corticosteroids and immunosuppressive drugs, so there is also a need for alternative treatments with less side effects. […] Further CPGs should focus on MCTD diagnosis, evaluations, treatment and patients needs.

• #103 Connective Tissue Diseases: Outlook, Treatment, and Types

  https://www.healthline.com/health/connective-tissue-disease

  Work with your doctor to develop the right treatment plan based on your diagnosis and needs. […] Breakthroughs in genetic therapies, where certain problem genes are silenced, hold promise for genetic connective tissue diseases. […] For someone living with Ehlers-Danlos syndrome or Marfan syndrome, surgery on an aortic aneurysm can be lifesaving. These operations are particularly successful if performed prior to rupture.

• #104 Mixed Connective-Tissue Disease (MCTD) Medication: Nonsteroidal anti-inflammatory drugs (NSAIDs), Proton pump inhibitors, Antimalarial agents, Corticosteroids, Phosphodiesterase (type 5) enzyme inhibitor, Endothelin receptor antagonists, Prostaglandins, I

  https://emedicine.medscape.com/article/335815-medication

  MCTD-related interstitial lung disease (ILD) is conventionally treated with corticosteroids in combination with steroid-sparing agents such as cyclophosphamide, azathioprine, or mycophenolate. […] The RECITAL trial, which included patients with MCTD, found that rituximab was noninferior to cyclophosphamide for treatment of ILD, and was associated with fewer adverse effects. […] The INBUILD trial, which included patients with MCTD, reported that treatment with the antifibrotic tyrosine kinase inhibitor nintedanib can significantly slow the annual rate of decline in forced vital capacity (FVC) in patients with progressive fibrosing ILDs. […] DMARDs used in the management of rheumatoid arthritis can be relevant in MCTD, in which a significant subset of patients have clinical manifestations that include those of chronic erosive polyarthritis, as is seen in rheumatoid arthritis. […] Increasingly, targeted therapies effective against other rheumatic diseases are emerging that may find a place in therapy for the overlapping rheumatic features in MCTD patients. A notable example is belimumab, a B-cell survival inhibitor that is approved for use in lupus.

• #105 Mixed connective tissue disease: What to know

  https://www.medicalnewstoday.com/articles/mixed-connective-tissue-disease

  The treatment of MCTD aims to manage symptoms, reduce inflammation, and suppress the immune systems atypical response. This typically involves medications such as: […] Nonsteroidal anti-inflammatory drugs (NSAIDs): NSAIDs can help manage pain, reduce inflammation, and relieve symptoms such as joint pain and swelling. […] Corticosteroids: These powerful anti-inflammatory drugs can help to suppress the immune system. They effectively reduce inflammation and manage symptoms, but long-term use can have side effects. […] Disease-modifying antirheumatic drugs (DMARDs): These medications slow the progression of MCTD and prevent joint damage. Examples of DMARDs include methotrexate, hydroxychloroquine, and azathioprine. Some suppress the immune system, but hydroxychloroquine does not. […] Immunosuppressive agents: In more severe cases, medications that further suppress the immune system may be necessary to reduce inflammation and prevent organ damage. Examples include cyclophosphamide and mycophenolate mofetil. […] Biologic therapies: These newer medications, such as rituximab, target specific immune system components and can effectively manage MCTD symptoms. […] Some individuals need continuous treatment with medications, while others may only need to take them during flare-ups.

• #106 Understanding Connective Tissue Diseases: Symptoms, Risks, and Treatment

  https://www.rupahealth.com/post/understanding-connective-tissue-diseases-symptoms-risks-and-treatment

  Physical therapy plays a key role in maintaining function and mobility for patients with CTDs. […] Occupational therapy helps patients manage daily activities and maintain independence. […] A comprehensive, multi-disciplinary approach to managing connective tissue diseases improves long-term patient outcomes. […] Effective management of CTDs through early detection, ongoing care, and a proactive approach can improve patient’s quality of life and reduce the risk of severe complications.

• #107 Mixed connective tissue disease – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mixed-connective-tissue-disease/diagnosis-treatment/drc-20375152

  There’s no cure for mixed connective tissue disease. Medication can help manage the signs and symptoms. […] The type of medication prescribed depends on the severity of your disease and your symptoms. Medications can include: […] Corticosteroids. Drugs, such as prednisone (Deltasone, Rayos), can help prevent your immune system from attacking healthy cells and suppress inflammation. Side effects of corticosteroids can include mood swings, weight gain, high blood sugar, increased blood pressure, weakened bones and cataracts. […] Antimalarial drugs. Hydroxychloroquine (Plaquenil) can treat mild mixed connective tissue disease and might prevent flare-ups. […] Calcium channel blockers. This category of medications, including nifedipine (Adalat CC, Procardia) and amlodipine (Norvasc), that help relax the muscles in the walls of your blood vessels might be used to treat Raynaud’s phenomenon.

• #108 Mixed Connective Tissue Disease (MCTD): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15039-mixed-connective-tissue-disease

  Treatment for MCTD depends on which organs are affected, your symptoms and how severe your condition is. Some people may need treatment only during flare-ups, while others may require constant care. Theres no cure for the disease, but medication can help you manage your symptoms. MCTD medications may include: […] Corticosteroids. For mild cases of MCTD, low-dose corticosteroids like prednisone can reduce inflammation and prevent your immune system from attacking healthy cells. Higher doses may be needed for moderate to severe MCTD. […] Antimalarial drugs. Antimalarial drugs like hydroxychloroquine may help prevent flare-ups and can treat mild mixed connective tissue disease. […] Calcium channel blockers. To treat Raynauds phenomenon, your provider may suggest a calcium channel blocker to help relax the muscles in the walls of your blood vessels.

• #109 Mixed Connective Tissue Disease: Symptoms, Causes, and Treatment

  https://www.healthline.com/health/mixed-connective-tissue-disease

  Theres no cure for MCTD, but it can usually be managed with medication and lifestyle changes. […] Since this disease can affect various organs such as skin, muscle, the digestive system and lungs, as well as your joints, treatment is targeted to manage the major areas of involvement. […] First-line agents such as nonsteroidal anti-inflammatory agents can be used initially, but some patients may require more advanced treatment with the antimalarial drug hydroxychloroquine (Plaquenil) or other disease-modifying agents and biologics. […] Medication can help manage the symptoms of MCTD. Some people only require treatment of their disease when it flares up, but others may need long-term treatment. […] Medications used to treat MCTD include: Nonsteroidal anti-inflammatory drugs (NSAIDs). Over-the-counter NSAIDs, such as ibuprofen (Advil, Motrin) and naproxen (Aleve), can treat joint pain and inflammation.

• #110 Mixed Connective Tissue Disease (MCTD) – Bone, Joint, and Muscle Disorders – Merck Manual Consumer Version

  https://www.merckmanuals.com/home/bone-joint-and-muscle-disorders/systemic-rheumatic-diseases/mixed-connective-tissue-disease-mctd

  Treatment varies depending on the severity of symptoms and may include nonsteroidal anti-inflammatory drugs, hydroxychloroquine, corticosteroids and other immunosuppressants, or a combination. […] The treatment of mixed connective tissue disease is similar to that of lupus, systemic sclerosis, and idiopathic inflammatory myopathy. Corticosteroids (a type of immunosuppressant) are usually effective, especially when the disease is diagnosed early. […] People who have mild disease can be treated with nonsteroidal anti-inflammatory drugs (NSAIDs), antimalarials (such as hydroxychloroquine or chloroquine), or very low doses of corticosteroids. […] People who have moderate to severe disease are given corticosteroids and sometimes other immunosuppressants (such as azathioprine, methotrexate, or mycophenolate mofetil).

• #111 Mixed Connective-Tissue Disease (MCTD) Medication: Nonsteroidal anti-inflammatory drugs (NSAIDs), Proton pump inhibitors, Antimalarial agents, Corticosteroids, Phosphodiesterase (type 5) enzyme inhibitor, Endothelin receptor antagonists, Prostaglandins, I

  https://emedicine.medscape.com/article/335815-medication

  Therapeutic options in mixed connective-tissue disease (MCTD) include the following: […] Arthritis/arthralgia can often be controlled with nonsteroidal anti-inflammatory drugs (NSAIDs); antimalarials (hydroxychloroquine); and, if needed, infrequent oral or intra-articular corticosteroid courses, typically at low dose. […] Disease-modifying antirheumatic drug (DMARD) therapy is reserved for more refractory synovitis, particularly if showing features of erosive/deforming risk. […] In patients with Raynaud phenomenon, calcium channel blockers are used. […] Phosphodiesterase inhibitors, endothelin receptor antagonists, or prostaglandins can be used for pulmonary hypertension. […] In some cases, pulmonary hypertension in MCTD may also respond to aggressive immunosuppression, similar to that used in interstitial lung disease therapy.

• #112 Mixed Connective Tissue Disease (MCTD): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/15039-mixed-connective-tissue-disease

  Quitting smoking. Smoking narrows your blood vessels, which makes the effects of Raynauds phenomenon worse. […] Reducing stress. Stress can trigger Raynauds phenomenon. Reduce your stress levels and practice relaxation techniques. Mental healthcare can also help you cope with stress. […] Long-term corticosteroid use can lead to side effects like: […] Bone loss due to osteoporosis […] Tissue death due to lack of blood flow (ischemia) […] Muscle weakness […] Infections […] Cushing syndrome. […] You must see your healthcare provider on a regular basis to monitor and control these possible effects. […] People who have a long-term, incurable condition like MCTD should develop ways of dealing with their disease. This includes: […] Seeking advice from your primary care provider.

• #113

  https://arthritis.ca/about-arthritis/arthritis-types-(a-z)/types/mixed-connective-tissue-disease-(mctd)

  The optimal treatment is what is best in each individual case so speak with your specialist about what kind of medications are most appropriate for you for several features of the disease. […] A physiotherapist (PT) can develop an individualized program designed to help you increase your strength, flexibility, range-of-motion, and general mobility and exercise tolerance through a wide variety of therapeutic treatments and strategies. […] An occupational therapist (OT) trained in arthritis management can analyze everything you do in a day and develop a program to help you protect your joints and minimize fatigue. […] In addition to following your treatment plan, there is a lot you can do yourself to help decrease your pain and increase your movement. Physiotherapy, occupational therapy, regular exercise and relaxation techniques are very important parts of your overall treatment plan.

• #114 What Is Mixed Connective Tissue Disease (MCTD)? Symptoms, Diagnosis, Treatment, and More

  https://www.webmd.com/lupus/what-is-mixed-connective-tissue-disease

  Medications may be given to treat a condition called pulmonary hypertension, which is the most common cause of death in people with MCTD. You may be given medication and asked to take precautions to treat or prevent Raynauds phenomenon (decreased blood flow to your fingers). […] People who have MCTD may find it easier to deal with the condition by seeking the help of mental health professionals, nutritionists, and support groups. With proper care and treatment, 80% of people with MCTD can live at least 10 years after the diagnosis of the condition.

• #115 What is Mixed Connective Tissue Disease? How is it diagnosed and how is it treated? | Centro Médico Teknon

  https://www.teknon.es/en/especialidades/castro-dominguez-francisco/frequent-questions/mixed-connective-tissue-disease-diagnosed-treated

  Monitoring and Follow-Up: Regular monitoring for disease activity, organ function, and potential side effects of medications is essential. Close collaboration with a rheumatologist and other specialists may be necessary. […] The management of Mixed Connective Tissue Disease requires a multidisciplinary approach, and treatment plans should be tailored to the individual’s specific symptoms and disease course. Periodic reassessment and adjustments to the treatment plan are often necessary to achieve optimal outcomes and manage potential complications. Early and accurate diagnosis, along with ongoing medical care, plays a crucial role in improving the prognosis and quality of life for individuals with Mixed Connective Tissue Disease.

Zobacz więcej